{
  "domain_code": "CPAT",
  "domain_name": "Clinical Psychopathology (DSM-5)",
  "total_passages": 560,
  "passages": [
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Overview of Anxiety Disorders",
      "passage_type": "definition",
      "passage": "Key Distinction: Fear vs. Anxiety Fear involves surges of autonomic arousal necessary for fight-or-flight, thoughts of immediate danger, and escape behaviors. Anxiety involves muscle tension, vigilance in preparation for future danger, and cautious or avoidant behaviors. Both can overlap, but the distinction is clinically important for differential diagnosis",
      "id": "CPAT-0001"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Obsessive-Compulsive Disorder (OCD)",
      "passage_type": "definition",
      "passage": "Obsessions vs. Compulsions Obsessions are recurrent, persistent, intrusive, and unwanted thoughts, urges, or images that cause marked anxiety or distress. The individual attempts to ignore, suppress, or neutralize them. Compulsions are repetitive behaviors or mental acts that the individual feels driven to perform in response to an obsession or according to rigid rules. They are aimed at preventing or reducing anxiety or a dreaded event but are not realistically connected to what they are designed to neutralize",
      "id": "CPAT-0002"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "definition",
      "passage": "Key Distinction: Duration Requirement The DSM-5 applies a differential duration threshold: 4 weeks for children and adolescents versus 6 months for adults. This reflects the recognition that brief separation fears are normative in childhood but more clinically significant when persistent in adulthood",
      "id": "CPAT-0003"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "definition",
      "passage": "Repetitive Behaviors in BDD The repetitive behaviors in BDD are compulsive in nature and functionally analogous to OCD compulsions. Common behaviors include: mirror checking (or mirror avoidance), excessive grooming, skin picking to remove perceived flaws, camouflaging (with makeup, clothing, hats, posture), reassurance seeking about appearance, comparing appearance with others, and excessive exercise (particularly in muscle dysmorphia). These behaviors are time-consuming and difficult to resist or control",
      "id": "CPAT-0004"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "definition",
      "passage": "Key Distinction: Hoarding Disorder vs. OCD Hoarding Hoarding in the context of hoarding disorder is ego-syntonic -- individuals value their possessions and experience distress at the thought of discarding them. Hoarding in the context of OCD is ego-dystonic -- the accumulation is driven by obsessions (e.g., fear of contamination preventing disposal, need for symmetry/completeness) and is experienced as unwanted. This distinction is critical for differential diagnosis and treatment planning",
      "id": "CPAT-0005"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "definition",
      "passage": "Pulling Styles Trichotillomania typically involves two styles of pulling: focused pulling (deliberate pulling in response to a negative emotion or urge, with full awareness) and automatic pulling (pulling that occurs outside of awareness, often during sedentary activities such as reading, watching TV, or talking on the phone). Most individuals engage in a mixture of both styles. Note that while the DSM-IV required a rising tension-before and relief-after cycle, the DSM-5 removed this criterion , as research showed many individuals do not experience this pattern",
      "id": "CPAT-0006"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "definition",
      "passage": "Behavioral Pattern Like trichotillomania, excoriation disorder involves both focused picking (deliberate, in response to negative emotions or urges) and automatic picking (outside of awareness, during sedentary activities). The picking may target healthy skin, minor skin irregularities (e.g., pimples, calluses, scabs), or lesions from previous picking. Common sites include the face, arms, and hands. Individuals may use fingernails, tweezers, pins, or other implements. A similar tension/relief cycle may be present, though it is not required for diagnosis",
      "id": "CPAT-0007"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl GAD has the highest comorbidity rate of any anxiety disorder. Approximately 90% of individuals with GAD have at least one comorbid disorder, most commonly MDD. The intolerance of uncertainty model  posits that individuals with GAD have difficulty tolerating ambiguous situations, which fuels the worry cycle",
      "id": "CPAT-0008"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Panic Disorder",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl The anxiety sensitivity model (Reiss & McNally, 1985) proposes that individuals with panic disorder have elevated fear of anxiety-related sensations themselves, believing these sensations have harmful consequences. Clark's (1986) cognitive model of panic emphasizes catastrophic misinterpretation of benign bodily sensations as the core mechanism",
      "id": "CPAT-0009"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Pharmacotherapy",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl For OCD specifically, the combination of ERP with an SSRI produces the best outcomes. The NICE guidelines recommend stepped care: (1) low-intensity CBT including ERP for mild OCD, (2) higher-intensity CBT with ERP or SSRI for moderate OCD, (3) combined CBT/ERP plus SSRI for severe OCD, and (4) clomipramine or augmentation with an antipsychotic for treatment-resistant cases. Approximately 40-60% of OCD patients are classified as treatment-resistant with first-line approaches",
      "id": "CPAT-0010"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Course",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Somatic complaints, particularly headaches and stomachaches , are a hallmark presentation in children with separation anxiety disorder, especially on school mornings or in anticipation of separation. These physical symptoms often lead to medical evaluation before the anxiety disorder is identified. In adults, separation anxiety frequently manifests as excessive concern about the well-being of children or a spouse and reluctance to be apart from them",
      "id": "CPAT-0011"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Clinical Features",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl BDD carries a significantly elevated suicide risk , with approximately 80% of individuals reporting lifetime suicidal ideation and 24-28% reporting suicide attempts. Comorbidity is high: approximately 75% of individuals with BDD have comorbid major depressive disorder , and 30-40% have comorbid OCD. Cosmetic procedures rarely improve BDD symptoms and may worsen them. Individuals with absent insight may present with delusional intensity and were historically diagnosed with \"delusional disorder, somatic type,\" but DSM-5 allows the BDD diagnosis regardless of insight level",
      "id": "CPAT-0012"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Clinical Features",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Treatment for excoriation disorder closely parallels that for trichotillomania. Habit reversal training (HRT) combined with CBT is the first-line psychotherapy. The treatment approach includes awareness training to identify triggers and high-risk situations, competing response training to substitute incompatible behaviors, and stimulus control strategies (e.g., covering mirrors, wearing gloves, keeping hands occupied). SSRIs are sometimes used but evidence is mixed. N-acetylcysteine has also shown preliminary efficacy as a glutamate-modulating agent",
      "id": "CPAT-0013"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Specific Phobias",
      "passage_type": "example",
      "passage": "EPPP Example A patient faints at the sight of blood during a medical procedure. Unlike other phobias that involve sustained sympathetic arousal, BII phobia involves an initial sympathetic spike followed by a parasympathetic rebound, producing bradycardia and hypotension. This is why applied tension (Ost & Sterner, 1987) is the treatment of choice for BII phobia, rather than standard relaxation techniques",
      "id": "CPAT-0014"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "example",
      "passage": "EPPP Example Distinguishing OCD from OCPD: In OCD, obsessions are ego-dystonic (experienced as unwanted and distressing). In OCPD, the preoccupation with orderliness and perfectionism is ego-syntonic (consistent with the person's self-image). Individuals with OCPD rarely seek treatment for these traits because they see them as desirable",
      "id": "CPAT-0015"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Overview of Anxiety Disorders",
      "passage_type": "paragraph",
      "passage": "Anxiety disorders are among the most prevalent psychiatric conditions, affecting approximately 31% of adults at some point during their lives . The DSM-5 categorizes anxiety disorders as conditions characterized by excessive fear and anxiety along with related behavioral disturbances. Fear is the emotional response to a real or perceived imminent threat, while anxiety is the anticipation of a future threat",
      "id": "CPAT-0016"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Overview of Anxiety Disorders",
      "passage_type": "paragraph",
      "passage": "Anxiety disorders differ from normal developmental anxiety by being excessive, persistent (typically lasting 6 months or more), and causing clinically significant distress or impairment. The DSM-5 reorganized the anxiety chapter by removing OCD and PTSD into their own chapters, though they share features with anxiety disorders",
      "id": "CPAT-0017"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Generalized Anxiety Disorder (GAD)",
      "passage_type": "paragraph",
      "passage": "Generalized Anxiety Disorder is characterized by persistent and excessive worry about a variety of domains, including work, health, family, finances, and everyday matters. The worry is difficult to control and is associated with at least three somatic or cognitive symptoms",
      "id": "CPAT-0018"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology",
      "passage_type": "paragraph",
      "passage": "Lifetime prevalence of GAD is approximately 5.7% in adults. Women are twice as likely as men to be diagnosed. GAD has a gradual onset, with a median age of onset of 30 years, which is later than most other anxiety disorders. It tends to follow a chronic, waxing-and-waning course",
      "id": "CPAT-0019"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Specific Phobias",
      "passage_type": "paragraph",
      "passage": "Specific phobia involves marked and disproportionate fear or anxiety about a specific object or situation that is actively avoided or endured with intense distress. The DSM-5 identifies five specifier subtypes:",
      "id": "CPAT-0020"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Specific Phobias",
      "passage_type": "paragraph",
      "passage": "Specific phobias are the most common anxiety disorder, with a lifetime prevalence of approximately 12.5%. They are often acquired through direct traumatic experience, observation, or informational transmission",
      "id": "CPAT-0021"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Social Anxiety Disorder",
      "passage_type": "paragraph",
      "passage": "Social Anxiety Disorder (SAD) involves marked fear or anxiety about social situations in which the individual may be scrutinized by others. The individual fears acting in a way that will be negatively evaluated, leading to humiliation, embarrassment, or rejection",
      "id": "CPAT-0022"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Key Features",
      "passage_type": "paragraph",
      "passage": "SAD has a lifetime prevalence of approximately 12% in the United States and typically begins in the mid-teens, often following a history of social inhibition or shyness. The performance only specifier was new in DSM-5 and distinguishes individuals whose fears are restricted to public speaking or performance contexts",
      "id": "CPAT-0023"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Panic Disorder",
      "passage_type": "paragraph",
      "passage": "Panic disorder is characterized by recurrent, unexpected panic attacks -- abrupt surges of intense fear or discomfort that reach a peak within minutes. At least one attack must be followed by one month or more of persistent concern about additional attacks or maladaptive behavioral changes related to the attacks",
      "id": "CPAT-0024"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Agoraphobia",
      "passage_type": "paragraph",
      "passage": "In DSM-5, agoraphobia is diagnosed as a separate disorder from panic disorder. It involves marked fear or anxiety about two or more of the following five situations: using public transportation, being in open spaces, being in enclosed places, standing in line or being in a crowd, and being outside of the home alone. The fear is that escape might be difficult or help unavailable in the event of panic-like symptoms",
      "id": "CPAT-0025"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Agoraphobia",
      "passage_type": "paragraph",
      "passage": "Approximately one-third to one-half of individuals with panic disorder also develop agoraphobia. Notably, agoraphobia can occur without a history of panic disorder",
      "id": "CPAT-0026"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Obsessive-Compulsive Disorder (OCD)",
      "passage_type": "paragraph",
      "passage": "OCD is characterized by the presence of obsessions, compulsions, or both. Although OCD was reclassified into its own chapter in DSM-5 (Obsessive-Compulsive and Related Disorders), it remains a commonly tested topic tested alongside anxiety disorders on the EPPP",
      "id": "CPAT-0027"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "paragraph",
      "passage": "The DSM-5 includes an insight specifier for OCD: good or fair insight, poor insight, or absent insight/delusional beliefs. Approximately 4% of individuals with OCD have absent insight, meaning they are completely convinced their OCD beliefs are true",
      "id": "CPAT-0028"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "paragraph",
      "passage": "The tic-related specifier applies when the individual has a current or past history of a tic disorder. Tic-related OCD has an earlier onset, more frequent male predominance, and higher rates of symmetry/ordering compulsions",
      "id": "CPAT-0029"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Behavioral Models",
      "passage_type": "paragraph",
      "passage": "Mowrer's (1960) two-factor theory remains foundational. Fear is initially acquired through classical conditioning (Factor 1) and maintained through operant conditioning via negative reinforcement of avoidance behavior (Factor 2). This model provides the rationale for exposure and response prevention (ERP) , the gold-standard behavioral treatment for OCD and many anxiety disorders",
      "id": "CPAT-0030"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Separation Anxiety Disorder",
      "passage_type": "paragraph",
      "passage": "Separation Anxiety Disorder is characterized by developmentally inappropriate and excessive fear or anxiety concerning separation from attachment figures. While historically categorized as a childhood-onset disorder in DSM-IV, the DSM-5 moved it to the anxiety disorders chapter, recognizing that it can be diagnosed across the lifespan, including in adults",
      "id": "CPAT-0031"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Course",
      "passage_type": "paragraph",
      "passage": "Separation anxiety disorder is the most common anxiety disorder in children under 12 , with a prevalence of approximately 4% in children and 1-2% in adults. Onset typically occurs in childhood, though adult-onset cases are increasingly recognized. The disorder tends to fluctuate in severity and may re-emerge during periods of stress",
      "id": "CPAT-0032"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Differential Diagnosis",
      "passage_type": "paragraph",
      "passage": "Separation anxiety disorder must be distinguished from agoraphobia (fear of being unable to escape, not specifically about separation from attachment figures), generalized anxiety disorder (worry about multiple topics, not limited to separation), and social anxiety disorder (avoidance of social scrutiny, not separation). In children, school refusal may stem from separation anxiety, social anxiety, or specific phobia of the school environment, and careful assessment is needed to determine the primary driving fear",
      "id": "CPAT-0033"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Body Dysmorphic Disorder (BDD)",
      "passage_type": "paragraph",
      "passage": "Body Dysmorphic Disorder is classified under Obsessive-Compulsive and Related Disorders in the DSM-5. It is characterized by a preoccupation with one or more perceived defects or flaws in physical appearance that are not observable or appear only slight to others. Despite the minimal or nonexistent nature of the appearance concerns, individuals with BDD experience significant distress and functional impairment",
      "id": "CPAT-0034"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Clinical Features",
      "passage_type": "paragraph",
      "passage": "BDD has a point prevalence of approximately 2% in the general population, with higher rates (7-8%) in dermatology and cosmetic surgery settings. Onset is typically during adolescence (mean age 16-17), and the course is usually chronic without treatment. The most common areas of concern involve the skin (e.g., acne, scars, wrinkles), hair (e.g., thinning, excessive body hair), and nose, though any body part can be the focus",
      "id": "CPAT-0035"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Treatment",
      "passage_type": "paragraph",
      "passage": "CBT with exposure and response prevention (ERP) is the first-line psychotherapy for BDD. Exposure involves confronting avoided situations (e.g., going out without camouflage, reducing mirror checking), while response prevention targets the repetitive behaviors. SSRIs are the first-line pharmacological treatment, often at higher doses similar to those used for OCD. Serotonergic medications are significantly more effective than non-serotonergic medications for BDD",
      "id": "CPAT-0036"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Hoarding Disorder",
      "passage_type": "paragraph",
      "passage": "Hoarding Disorder was introduced as a standalone diagnosis in the DSM-5, classified under Obsessive-Compulsive and Related Disorders. Previously, hoarding was considered a symptom or subtype of OCD. Research has demonstrated that hoarding is a distinct condition with unique neurobiological, cognitive, and behavioral features that warrant independent diagnostic status",
      "id": "CPAT-0037"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Course",
      "passage_type": "paragraph",
      "passage": "Hoarding disorder has a prevalence of approximately 2-6% in the general population, making it substantially more common than OCD. Symptoms typically emerge in adolescence (ages 11-15), become clinically significant in the mid-20s to 30s, and worsen progressively with age. The disorder is equally prevalent in males and females, though clinical samples are predominantly female. Hoarding disorder is associated with significant health and safety risks, including fire hazards, falls, unsanitary living conditions, and social isolation",
      "id": "CPAT-0038"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Trichotillomania (Hair-Pulling Disorder)",
      "passage_type": "paragraph",
      "passage": "Trichotillomania , also known as hair-pulling disorder, is classified under Obsessive-Compulsive and Related Disorders in the DSM-5. It is a body-focused repetitive behavior disorder characterized by the recurrent, compulsive pulling out of one's own hair, resulting in noticeable hair loss",
      "id": "CPAT-0039"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Clinical Features",
      "passage_type": "paragraph",
      "passage": "Trichotillomania has a prevalence of approximately 1-2% and is significantly more common in females than males (approximately 10:1 ratio in adults). The most common sites of pulling are the scalp, eyebrows, and eyelids, though any body area with hair may be targeted. Onset is most common around puberty (ages 10-13). A subset of individuals engage in trichophagia (eating pulled hair), which can lead to trichobezoars (hairballs) requiring surgical removal -- a rare but potentially life-threatening complication",
      "id": "CPAT-0040"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Comorbidity",
      "passage_type": "paragraph",
      "passage": "Trichotillomania is frequently comorbid with excoriation (skin-picking) disorder , OCD, major depressive disorder, and other anxiety disorders. Co-occurrence with excoriation disorder is particularly common, reflecting the shared classification as body-focused repetitive behavior disorders",
      "id": "CPAT-0041"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Excoriation (Skin-Picking) Disorder",
      "passage_type": "paragraph",
      "passage": "Excoriation disorder , also known as skin-picking disorder or dermatillomania, is classified under Obsessive-Compulsive and Related Disorders in the DSM-5. It was newly added as a formal diagnosis in DSM-5 and, like trichotillomania, is categorized as a body-focused repetitive behavior disorder",
      "id": "CPAT-0042"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Epidemiology and Clinical Features",
      "passage_type": "paragraph",
      "passage": "Excoriation disorder has a prevalence of approximately 1.4% in the general population and is predominantly diagnosed in females (approximately 75% of cases). Onset can occur at any age but frequently begins in adolescence, often coinciding with or following the onset of acne or other dermatological conditions. The course is typically chronic, with waxing and waning symptom severity. Significant medical complications can include tissue damage, scarring, and infection",
      "id": "CPAT-0043"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Differential Diagnosis",
      "passage_type": "paragraph",
      "passage": "Excoriation disorder must be distinguished from: nonsuicidal self-injury (which involves intentional self-harm for emotional regulation, not repetitive picking driven by urge/habit), BDD (where skin picking is motivated by attempts to fix perceived appearance flaws), psychotic disorders (where picking may be driven by delusions of parasitosis or tactile hallucinations), and substance-induced picking (particularly stimulant-induced formication). When skin picking occurs exclusively in the context of one of these other conditions, excoriation disorder should not be diagnosed",
      "id": "CPAT-0044"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Overview of Disruptive, Impulse-Control, and Conduct Disorders",
      "passage_type": "definition",
      "passage": "Key Concept: Externalizing vs. Internalizing Disruptive and conduct disorders are classified as externalizing disorders , meaning the core symptoms are directed outward toward the environment (aggression, defiance, rule violation). This contrasts with internalizing disorders (e.g., depression, anxiety), where distress is directed inward. However, significant comorbidity between externalizing and internalizing disorders is common",
      "id": "CPAT-0045"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Onset Specifiers",
      "passage_type": "definition",
      "passage": "Childhood-Onset vs. Adolescent-Onset Childhood-onset type: At least one criterion characteristic of CD prior to age 10. Associated with more persistent aggression, worse prognosis, and higher likelihood of developing ASPD in adulthood. Adolescent-onset type: No criteria present prior to age 10. Associated with less aggression, more influence of deviant peers, and a better prognosis. Unspecified onset: Criteria met but insufficient information to determine onset",
      "id": "CPAT-0046"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Symptom Categories",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl DSM-5 added severity specifiers for ODD: mild (symptoms confined to one setting), moderate (some symptoms in at least two settings), and severe (symptoms in three or more settings). Research suggests the angry/irritable mood dimension of ODD is a stronger predictor of later internalizing disorders (depression, anxiety), while the behavioral dimensions predict later conduct disorder and ASPD (Stringaris & Goodman, 2009)",
      "id": "CPAT-0047"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "The Typical Pathway",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl ASPD in DSM-5 requires evidence of conduct disorder with onset before age 15 . Approximately 40% of children with childhood-onset CD develop ASPD. Moffitt's (1993) developmental taxonomy distinguishes life-course persistent antisocial behavior (beginning in childhood, neuropsychological deficits, poor prognosis) from adolescence-limited antisocial behavior (emerging in teen years, peer-influenced, typically resolves by adulthood)",
      "id": "CPAT-0048"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "The Callous-Unemotional (CU) Specifier",
      "passage_type": "example",
      "passage": "EPPP Example Children with CD and CU traits show distinct neurobiological features: reduced amygdala reactivity to fearful facial expressions, lower cortisol reactivity to stress, and diminished autonomic arousal . They tend to show proactive (instrumental) aggression rather than reactive aggression, and they respond poorly to punishment-based interventions but may respond to reward-based approaches",
      "id": "CPAT-0049"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Child/Adolescent-Focused Interventions",
      "passage_type": "example",
      "passage": "EPPP Example For children with CU traits, standard punishment-based approaches are less effective because these children show reduced sensitivity to punishment cues. Reward-based approaches emphasizing positive reinforcement are recommended instead. Dadds et al. (2012) demonstrated that targeting emotion recognition and empathy through parent-mediated interventions can improve outcomes for children with CU traits",
      "id": "CPAT-0050"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Overview of Disruptive, Impulse-Control, and Conduct Disorders",
      "passage_type": "paragraph",
      "passage": "This DSM-5 chapter groups disorders characterized by problems in the self-regulation of emotions and behaviors. These conditions manifest as behaviors that violate the rights of others (e.g., aggression, destruction of property) and/or bring the individual into significant conflict with societal norms or authority figures. These disorders are more common in males and typically have onset in childhood or adolescence",
      "id": "CPAT-0051"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Oppositional Defiant Disorder (ODD)",
      "passage_type": "paragraph",
      "passage": "Oppositional Defiant Disorder is a pattern of angry/irritable mood, argumentative/defiant behavior, or vindictiveness lasting at least 6 months, evidenced by at least four symptoms from three categories:",
      "id": "CPAT-0052"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Symptom Categories",
      "passage_type": "paragraph",
      "passage": "ODD prevalence is approximately 3.3%, with a male predominance in childhood that equalizes by adolescence. It typically emerges in the preschool years and is usually evident before age 8. ODD often precedes the development of conduct disorder, but the majority of children with ODD do not progress to conduct disorder",
      "id": "CPAT-0053"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Conduct Disorder (CD)",
      "passage_type": "paragraph",
      "passage": "Conduct Disorder involves a repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms are violated. The DSM-5 requires at least 3 of 15 criteria in the past 12 months, with at least 1 criterion present in the past 6 months, across four categories:",
      "id": "CPAT-0054"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "The Callous-Unemotional (CU) Specifier",
      "passage_type": "paragraph",
      "passage": "The DSM-5 added the specifier \"with limited prosocial emotions\" (the callous-unemotional traits specifier). To qualify, the individual must display at least two of the following persistently over at least 12 months and in multiple settings:",
      "id": "CPAT-0055"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Intermittent Explosive Disorder (IED)",
      "passage_type": "paragraph",
      "passage": "Intermittent Explosive Disorder is characterized by recurrent behavioral outbursts representing a failure to control aggressive impulses. The outbursts are grossly out of proportion to the provocation and are not premeditated",
      "id": "CPAT-0056"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "The Developmental Trajectory to Antisocial Personality Disorder",
      "passage_type": "paragraph",
      "passage": "One of the most important concepts for the EPPP is the developmental progression from childhood disruptive behavior to adult Antisocial Personality Disorder (ASPD) . This trajectory is well-established but not inevitable",
      "id": "CPAT-0057"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Overview of Feeding and Eating Disorders",
      "passage_type": "definition",
      "passage": "Key Concept: Transdiagnostic Model Fairburn's (2003) transdiagnostic model proposes that eating disorders share a core psychopathology: the over-evaluation of eating, shape, and weight, and their control. This model is the basis for enhanced cognitive-behavioral therapy (CBT-E), which can be applied across eating disorder diagnoses",
      "id": "CPAT-0058"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Avoidant/Restrictive Food Intake Disorder (ARFID)",
      "passage_type": "definition",
      "passage": "Key Distinction Unlike AN, ARFID does not involve distress about body shape or weight, nor fear of weight gain. The food avoidance may be based on sensory characteristics of food (texture, color, smell), concern about aversive consequences of eating (e.g., choking, vomiting), or apparent lack of interest in eating. ARFID can occur in children and adults",
      "id": "CPAT-0059"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Subtypes",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl DSM-5 made several important changes to AN criteria: (1) removed the specific BMI threshold and the word \"refusal\" to eat, replacing it with \"restriction\"; (2) removed the amenorrhea criterion, recognizing that AN occurs in males and post-menopausal women; (3) Criterion B no longer requires explicit acknowledgment of fear of weight gain -- persistent behavior interfering with weight gain suffices",
      "id": "CPAT-0060"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Insomnia Disorder",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Cognitive-Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment, more effective than pharmacotherapy in the long term. Key components include stimulus control (bed only for sleep and sex), sleep restriction, sleep hygiene education, cognitive restructuring, and relaxation training. Spielman's (1987) 3P model of insomnia identifies predisposing, precipitating, and perpetuating factors",
      "id": "CPAT-0061"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Types",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl The suprachiasmatic nucleus (SCN) of the hypothalamus is the master circadian pacemaker. It is primarily entrained (synchronized) by light input via the retinohypothalamic tract. Melatonin , produced by the pineal gland under SCN control, promotes sleep onset and is used therapeutically for circadian rhythm disorders. Light therapy (bright light exposure) is the primary treatment for delayed sleep-wake phase disorder and seasonal affective disorder",
      "id": "CPAT-0062"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "example",
      "passage": "EPPP Example A key differential: AN binge-eating/purging type vs. BN. The distinguishing factor is body weight . If the individual is at a significantly low body weight and meets AN criteria, the diagnosis is AN binge-eating/purging type, even if binge-purge cycles are present. BN is diagnosed when the individual is at or above minimally normal weight. Note that BN no longer has purging/nonpurging subtypes in DSM-5",
      "id": "CPAT-0063"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Rumination Disorder",
      "passage_type": "example",
      "passage": "EPPP Example Key distinctions: Pica involves eating nonfood substances (not regurgitation) and is not diagnosed before age 2. Rumination disorder involves regurgitation of previously ingested food (not nonfood substances). Both require at least 1 month duration and both can occur across the lifespan but must be distinguished from developmentally normal behaviors and medical conditions",
      "id": "CPAT-0064"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Psychological and Sociocultural Factors",
      "passage_type": "example",
      "passage": "EPPP Example Treatment approaches differ by disorder: CBT-E (enhanced cognitive-behavioral therapy) is the first-line treatment for BN and BED. For AN, family-based treatment (FBT/Maudsley approach) is the best-supported treatment for adolescents, empowering parents to take charge of refeeding. For adults with AN, no single therapy has demonstrated clear superiority, though CBT-E, MANTRA (Maudsley model of anorexia treatment), and specialist supportive clinical management have the most evidence. Fluoxetine at 60 mg/day is effective for BN but medications have limited efficacy for AN",
      "id": "CPAT-0065"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Parasomnias",
      "passage_type": "example",
      "passage": "EPPP Example Distinguishing sleep terrors from nightmares: Sleep terrors occur during NREM Stage N3 (deep sleep), involve intense autonomic arousal, and the individual is typically amnestic for the episode. Nightmares occur during REM sleep, the individual fully awakens with recall of the dream content, and there is less autonomic arousal. Sleep terrors are most common in children ages 4-12 and typically resolve spontaneously",
      "id": "CPAT-0066"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Overview of Feeding and Eating Disorders",
      "passage_type": "paragraph",
      "passage": "The DSM-5 chapter on feeding and eating disorders includes conditions characterized by persistent disturbances in eating or eating-related behavior that result in altered consumption or absorption of food, causing significant impairment in physical health or psychosocial functioning. These disorders have among the highest mortality rates of any psychiatric condition, particularly anorexia nervosa",
      "id": "CPAT-0067"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Anorexia Nervosa (AN)",
      "passage_type": "paragraph",
      "passage": "Anorexia nervosa is characterized by restriction of energy intake leading to a significantly low body weight, intense fear of gaining weight, and disturbance in the way body weight or shape is experienced",
      "id": "CPAT-0068"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Medical Complications",
      "passage_type": "paragraph",
      "passage": "AN has the highest mortality rate of any psychiatric disorder, approximately 5-10% per decade of illness. Deaths result from medical complications (cardiac arrhythmias, electrolyte imbalances) and suicide. Key medical findings include bradycardia, hypotension, lanugo hair, osteoporosis, and refeeding syndrome (dangerous electrolyte shifts upon nutritional restoration, particularly hypophosphatemia)",
      "id": "CPAT-0069"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Bulimia Nervosa (BN)",
      "passage_type": "paragraph",
      "passage": "Bulimia nervosa involves recurrent episodes of binge eating followed by inappropriate compensatory behaviors to prevent weight gain",
      "id": "CPAT-0070"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "paragraph",
      "passage": "Medical complications of BN include dental erosion (from stomach acid), parotid gland enlargement (\"chipmunk cheeks\"), Russell's sign (calluses on the knuckles from self-induced vomiting), esophageal tears (Mallory-Weiss syndrome), and metabolic alkalosis from purging",
      "id": "CPAT-0071"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Binge-Eating Disorder (BED)",
      "passage_type": "paragraph",
      "passage": "Binge-Eating Disorder was elevated to a full diagnosis in DSM-5 (it was in the appendix of DSM-IV). It involves recurrent binge eating episodes without the regular use of compensatory behaviors",
      "id": "CPAT-0072"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Binge-Eating Episode Features (3 or more)",
      "passage_type": "paragraph",
      "passage": "Episodes occur at least once per week for 3 months . Marked distress regarding binge eating is present. BED is the most common eating disorder, with a lifetime prevalence of approximately 2.8%. It is associated with obesity but not all individuals with BED are obese, and not all obese individuals have BED",
      "id": "CPAT-0073"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Avoidant/Restrictive Food Intake Disorder (ARFID)",
      "passage_type": "paragraph",
      "passage": "ARFID is a new diagnosis in DSM-5, replacing and expanding the DSM-IV diagnosis of \"feeding disorder of infancy or early childhood.\" It involves an eating or feeding disturbance manifested by persistent failure to meet nutritional needs, associated with significant weight loss, nutritional deficiency, dependence on enteral feeding or supplements, or marked interference with psychosocial functioning",
      "id": "CPAT-0074"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Pica and Rumination Disorder",
      "passage_type": "paragraph",
      "passage": "The DSM-5 feeding and eating disorders chapter includes two additional conditions that are commonly tested: Pica and Rumination Disorder . These may co-occur with intellectual disability, autism spectrum disorder, or other conditions",
      "id": "CPAT-0075"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Pica",
      "passage_type": "paragraph",
      "passage": "Pica is defined as the persistent eating of nonnutritive, nonfood substances for a period of at least 1 month . The diagnostic criteria require:",
      "id": "CPAT-0076"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Pica",
      "passage_type": "paragraph",
      "passage": "Pica is associated with intellectual disability, autism spectrum disorder (ASD), pregnancy, and iron deficiency . Substances commonly ingested include dirt, clay, chalk, paper, soap, cloth, hair, string, and paint chips. Medical complications can be serious and include bowel obstruction, intestinal perforation, lead poisoning (from paint chips), parasitic infections, and dental injury",
      "id": "CPAT-0077"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Rumination Disorder",
      "passage_type": "paragraph",
      "passage": "Rumination Disorder involves the repeated regurgitation of food for a period of at least 1 month . Regurgitated food may be re-chewed, re-swallowed, or spit out. The diagnostic criteria require:",
      "id": "CPAT-0078"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Rumination Disorder",
      "passage_type": "paragraph",
      "passage": "Rumination disorder can occur across the lifespan , from infancy through adulthood. In infants, it may present with characteristic straining and arching movements. Treatment typically involves habit reversal training (learning incompatible behaviors such as diaphragmatic breathing after meals) and behavioral interventions. Diaphragmatic breathing -- breathing deeply using the diaphragm to create abdominal pressure that counteracts regurgitation -- has the strongest evidence base for this condition",
      "id": "CPAT-0079"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Insomnia Disorder",
      "passage_type": "paragraph",
      "passage": "Insomnia disorder involves dissatisfaction with sleep quantity or quality, associated with difficulty initiating sleep, maintaining sleep, or early morning awakening with inability to return to sleep. The disturbance occurs at least 3 nights per week for at least 3 months , despite adequate opportunity for sleep. It causes clinically significant distress or impairment",
      "id": "CPAT-0080"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Narcolepsy",
      "passage_type": "paragraph",
      "passage": "Narcolepsy involves recurrent periods of irrepressible need to sleep, lapsing into sleep, or napping, occurring at least 3 times per week over the past 3 months, plus at least one of the following:",
      "id": "CPAT-0081"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Narcolepsy",
      "passage_type": "paragraph",
      "passage": "Narcolepsy Type 1 (with cataplexy/hypocretin deficiency) is caused by autoimmune destruction of hypocretin-producing neurons in the hypothalamus. Narcolepsy Type 2 is without cataplexy and with normal hypocretin levels",
      "id": "CPAT-0082"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Obstructive Sleep Apnea Hypopnea",
      "passage_type": "paragraph",
      "passage": "Obstructive sleep apnea involves repeated episodes of upper airway obstruction during sleep, manifested by snoring, gasping, or breathing pauses. Diagnosed by polysomnography showing 5 or more obstructive apneas or hypopneas per hour of sleep (apnea-hypopnea index, or AHI, of 5 or more) with associated symptoms, or 15 or more regardless of symptoms. Risk factors include obesity, male sex, older age, and craniofacial abnormalities",
      "id": "CPAT-0083"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Circadian Rhythm Sleep-Wake Disorders",
      "passage_type": "paragraph",
      "passage": "These disorders involve a persistent or recurrent pattern of sleep disruption primarily due to alteration of the circadian system or misalignment between the endogenous circadian rhythm and the sleep-wake schedule required by an individual's environment",
      "id": "CPAT-0084"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Overview of Depressive and Bipolar Disorders",
      "passage_type": "definition",
      "passage": "Mood Episode Types A major depressive episode involves at least 5 of 9 symptoms lasting 2 or more weeks, with depressed mood or anhedonia required. A manic episode involves abnormally elevated, expansive, or irritable mood with increased energy lasting at least 7 days (or any duration if hospitalization is required). A hypomanic episode meets the same symptom criteria as mania but lasts at least 4 consecutive days and does not cause marked impairment or psychotic features",
      "id": "CPAT-0085"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Beck's Cognitive Triad and Cognitive Theory",
      "passage_type": "definition",
      "passage": "The Cognitive Triad 1. Negative view of the self: \"I am worthless, inadequate, or defective.\" 2. Negative view of the world/experience: \"The world is unfair, and nothing works out for me.\" 3. Negative view of the future: \"Things will never get better; there is no hope.\"",
      "id": "CPAT-0086"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl DSM-5 removed the bereavement exclusion that was present in DSM-IV. Previously, depressive symptoms within 2 months of losing a loved one were excluded from an MDD diagnosis. The DSM-5 now allows MDD to be diagnosed even in the context of bereavement, recognizing that bereavement can trigger a full depressive episode",
      "id": "CPAT-0087"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Bipolar II Disorder",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Bipolar II is frequently misdiagnosed as MDD because patients typically present during depressive episodes and may not recognize hypomania as pathological. Screening for a history of elevated mood, decreased need for sleep, and increased activity is essential. Antidepressant monotherapy in unrecognized Bipolar II can precipitate a manic switch",
      "id": "CPAT-0088"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl PMDD diagnosis must be confirmed by prospective daily ratings for at least 2 consecutive symptomatic menstrual cycles . Retrospective self-report alone is insufficient because women often overestimate premenstrual symptom severity when recalling past cycles. This prospective confirmation requirement is unique among DSM-5 diagnoses",
      "id": "CPAT-0089"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Depression",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl The black box warning on antidepressants warns of increased suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24) during initial treatment. This does not mean antidepressants cause suicide -- the risk is that as energy and motivation return before mood improves, the individual may have increased capacity to act on suicidal thoughts. The net benefit of antidepressant treatment for depression far outweighs this risk",
      "id": "CPAT-0090"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Protective Factors",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl The Joiner interpersonal theory of suicide (2005) identifies three factors necessary for a lethal suicide attempt: thwarted belongingness (feeling disconnected), perceived burdensomeness (feeling like a burden to others), and acquired capability (reduced fear of death through habituation to pain and self-harm)",
      "id": "CPAT-0091"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Persistent Depressive Disorder (Dysthymia)",
      "passage_type": "example",
      "passage": "EPPP Example When a patient has PDD and also meets criteria for a major depressive episode, this is termed \"double depression.\" The prognosis for double depression is worse than for MDD alone, with higher relapse rates and greater functional impairment",
      "id": "CPAT-0092"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Treatment",
      "passage_type": "example",
      "passage": "EPPP Example PMDD is a new addition to the depressive disorders chapter in DSM-5. The key features to remember are: (1) symptoms must occur in the final week before menses and remit after onset; (2) at least one of four core affective symptoms is required; (3) prospective daily ratings over 2 cycles are required for confirmation; (4) SSRIs are effective even when used only during the luteal phase",
      "id": "CPAT-0093"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Overview of Depressive and Bipolar Disorders",
      "passage_type": "paragraph",
      "passage": "The DSM-5 separates mood disorders into two distinct chapters: Depressive Disorders and Bipolar and Related Disorders . This reorganization reflects growing evidence that bipolar disorders are more closely related to schizophrenia spectrum disorders in terms of genetics, symptomatology, and neurobiology. Mood disorders collectively represent one of the leading causes of disability worldwide (WHO, 2017)",
      "id": "CPAT-0094"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Five or more of the following symptoms present during the same 2-week period, representing a change from previous functioning. At least one must be (1) depressed mood or (2) loss of interest or pleasure ( anhedonia ):",
      "id": "CPAT-0095"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "The mnemonic SIG E CAPS (Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor changes, Suicidality) is commonly used to remember these criteria",
      "id": "CPAT-0096"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Persistent Depressive Disorder (Dysthymia)",
      "passage_type": "paragraph",
      "passage": "Persistent depressive disorder (PDD) consolidates what DSM-IV called dysthymic disorder and chronic major depressive disorder. It requires depressed mood for most of the day, for more days than not, for at least 2 years (1 year in children and adolescents), plus two or more of the following:",
      "id": "CPAT-0097"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Bipolar I Disorder",
      "passage_type": "paragraph",
      "passage": "Bipolar I disorder requires the occurrence of at least one manic episode. The manic episode may have been preceded by or followed by hypomanic or major depressive episodes, but these are not required for diagnosis. During a manic episode, at least three of the following symptoms are present (four if mood is only irritable):",
      "id": "CPAT-0098"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Bipolar I Disorder",
      "passage_type": "paragraph",
      "passage": "The mnemonic DIG FAST (Distractibility, Indiscretion/Impulsivity, Grandiosity, Flight of ideas, Activity increase, Sleep deficit, Talkativeness) helps recall mania criteria",
      "id": "CPAT-0099"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Bipolar II Disorder",
      "passage_type": "paragraph",
      "passage": "Bipolar II disorder requires at least one hypomanic episode and at least one major depressive episode. Bipolar II is not a \"milder\" form of Bipolar I -- the depressive episodes are often more chronic and debilitating. If a full manic episode ever occurs, the diagnosis changes to Bipolar I",
      "id": "CPAT-0100"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Cyclothymic Disorder",
      "passage_type": "paragraph",
      "passage": "Cyclothymic disorder involves chronic fluctuating mood disturbance with numerous periods of hypomanic symptoms and periods of depressive symptoms that do not meet full criteria for either a hypomanic or major depressive episode. Symptoms must be present for at least 2 years (1 year in children/adolescents), and the individual must not have been symptom-free for more than 2 months at a time. There is a 15-50% risk of eventually developing Bipolar I or II disorder",
      "id": "CPAT-0101"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Premenstrual Dysphoric Disorder (PMDD)",
      "passage_type": "paragraph",
      "passage": "Premenstrual Dysphoric Disorder (PMDD) is classified as a depressive disorder in the DSM-5. It involves the presence of 5 or more symptoms in the final week before the onset of menses, with symptoms beginning to improve within a few days after the onset of menses and becoming minimal or absent in the week post-menses",
      "id": "CPAT-0102"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Distinction from PMS",
      "passage_type": "paragraph",
      "passage": "Premenstrual Syndrome (PMS) is a common, less severe condition that affects up to 75% of menstruating women. PMDD is distinct from PMS in that PMDD causes significant functional impairment in social, occupational, or interpersonal domains, whereas PMS involves milder symptoms that do not substantially interfere with daily functioning. PMDD prevalence is estimated at 1.8-5.8% of menstruating women",
      "id": "CPAT-0103"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Beck's Cognitive Triad and Cognitive Theory",
      "passage_type": "paragraph",
      "passage": "Aaron Beck's (1967) cognitive theory of depression is one of the most influential models and is heavily tested on the EPPP. The theory proposes that depression results from negative cognitive patterns organized around three domains:",
      "id": "CPAT-0104"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Beck's Cognitive Triad and Cognitive Theory",
      "passage_type": "paragraph",
      "passage": "These negative views are maintained by cognitive distortions (systematic errors in thinking) such as arbitrary inference, selective abstraction, overgeneralization, magnification/minimization, personalization, and all-or-nothing thinking. The distortions arise from underlying depressogenic schemas -- stable cognitive structures formed through early experience that become activated by stressful life events",
      "id": "CPAT-0105"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Psychotherapy for Depression",
      "passage_type": "paragraph",
      "passage": "Cognitive-Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) have the strongest evidence base for treating depression. CBT targets cognitive distortions and behavioral activation. IPT focuses on interpersonal disputes, role transitions, grief, and interpersonal deficits. Behavioral Activation (BA) -- increasing engagement in positively reinforcing activities -- has emerged as an effective standalone treatment, with efficacy comparable to full CBT in some studies",
      "id": "CPAT-0106"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Overview of Neurodevelopmental Disorders",
      "passage_type": "definition",
      "passage": "Key Concept: Dimensional Approach DSM-5 moved toward a more dimensional approach for neurodevelopmental disorders, using severity levels and specifiers rather than rigid categorical subtypes. This is most evident in ASD (which consolidated previously separate diagnoses) and intellectual disability (which now emphasizes adaptive functioning over IQ scores for severity classification)",
      "id": "CPAT-0107"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "definition",
      "passage": "DSM-5 Changes from DSM-IV DSM-IV used a triad (social interaction, communication, restricted behaviors). DSM-5 collapsed this into a dyad : (1) social communication/interaction and (2) restricted/repetitive behaviors. The sensory reactivity criterion (B4) is new. Language delay is no longer part of the ASD criteria but can be noted as a specifier. Importantly, DSM-5 requires specifying severity levels for each domain",
      "id": "CPAT-0108"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Presentations",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Symptoms must be present in two or more settings (home, school, work), must be present for at least 6 months, and must interfere with or reduce the quality of functioning. ADHD persists into adulthood in approximately 50-65% of cases, though hyperactive-impulsive symptoms tend to decline more than inattentive symptoms . Executive function deficits (working memory, inhibition, cognitive flexibility) are central to Barkley's (1997) model of ADHD",
      "id": "CPAT-0109"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Behavioral and Psychosocial Interventions",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Common misconceptions about ADHD stimulant medications: (1) Stimulants do not cause a \"paradoxical\" calming effect unique to ADHD -- they enhance focus in most individuals; the difference is that individuals with ADHD show greater behavioral improvement. (2) The \"medication holiday\" debate: some families choose to stop medication on weekends/summers, but this may affect social functioning and self-esteem. (3) Long-term stimulant use may temporarily slow growth velocity by approximately 1-3 cm, but adult height appears largely unaffected",
      "id": "CPAT-0110"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Intellectual Disability (Intellectual Developmental Disorder)",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl A major DSM-5 change: severity levels (mild, moderate, severe, profound) are now determined by adaptive functioning rather than IQ score alone. While IQ testing is still used (approximately 2 standard deviations below the mean, or roughly IQ 65-75), the DSM-5 emphasizes that it is the level of adaptive support needed that determines severity. IQ scores are less valid at lower ranges and can be influenced by the Flynn effect and other measurement issues",
      "id": "CPAT-0111"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Severity Levels",
      "passage_type": "example",
      "passage": "EPPP Example Individuals previously diagnosed with Asperger's disorder under DSM-IV would now typically receive a diagnosis of ASD Level 1 (\"requiring support\") without accompanying intellectual or language impairment. The DSM-5 includes a note that individuals with well-established DSM-IV diagnoses should be given the ASD diagnosis, and those with marked deficits in social communication but not meeting RRB criteria may be evaluated for Social (Pragmatic) Communication Disorder , a new DSM-5 diagnosis",
      "id": "CPAT-0112"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Tic Disorder Hierarchy",
      "passage_type": "example",
      "passage": "EPPP Example Coprolalia (involuntary utterance of obscene words) is often associated with Tourette's in popular culture, but it actually occurs in only about 10-15% of individuals with Tourette's disorder. The most common initial tics are facial (eye blinking, grimacing). Tourette's is highly comorbid with ADHD (approximately 50%) and OCD (approximately 30%). The CSTC circuit implicated in OCD is also involved in tic disorders",
      "id": "CPAT-0113"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Overview of Neurodevelopmental Disorders",
      "passage_type": "paragraph",
      "passage": "Neurodevelopmental disorders are a group of conditions with onset in the developmental period, typically manifesting early in development and producing impairments in personal, social, academic, or occupational functioning. These disorders frequently co-occur with one another. The DSM-5 neurodevelopmental chapter includes intellectual disabilities, communication disorders, autism spectrum disorder, ADHD, specific learning disorder, and motor disorders (including tic disorders)",
      "id": "CPAT-0114"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Attention-Deficit/Hyperactivity Disorder (ADHD)",
      "passage_type": "paragraph",
      "passage": "ADHD is characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. DSM-5 made several important changes to ADHD criteria compared to DSM-IV",
      "id": "CPAT-0115"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Autism Spectrum Disorder (ASD)",
      "passage_type": "paragraph",
      "passage": "Autism Spectrum Disorder represents one of the most significant diagnostic changes in DSM-5. The previous DSM-IV categories of autistic disorder, Asperger's disorder, childhood disintegrative disorder, and PDD-NOS were consolidated into the single diagnosis of ASD",
      "id": "CPAT-0116"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Stimulant medications are the first-line pharmacological treatment for ADHD and are effective in approximately 70-80% of cases:",
      "id": "CPAT-0117"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Non-stimulant options include atomoxetine (Strattera, a norepinephrine reuptake inhibitor), guanfacine and clonidine (alpha-2 agonists), and bupropion (off-label). The MTA Study (Multimodal Treatment Study of ADHD, 1999) found that medication management was superior to behavioral treatment alone for core ADHD symptoms, while combined treatment was superior for functional outcomes and comorbid conditions",
      "id": "CPAT-0118"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Specific Learning Disorder",
      "passage_type": "paragraph",
      "passage": "Specific Learning Disorder (SLD) is a unified diagnosis in DSM-5 that replaced the separate DSM-IV categories of reading disorder, mathematics disorder, and disorder of written expression. It requires persistent difficulties learning keystone academic skills, with onset during school-age years",
      "id": "CPAT-0119"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Specifiers",
      "passage_type": "paragraph",
      "passage": "SLD affects approximately 5-15% of school-age children. It requires academic skills substantially below age expectations, confirmed by both clinical assessment and standardized testing. The DSM-5 does not require an IQ-achievement discrepancy, moving away from the discrepancy model toward a response to intervention (RTI) approach",
      "id": "CPAT-0120"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Intellectual Disability (Intellectual Developmental Disorder)",
      "passage_type": "paragraph",
      "passage": "Intellectual disability involves deficits in intellectual functions (reasoning, problem-solving, abstract thinking, academic learning) and adaptive functioning (conceptual, social, and practical domains) with onset during the developmental period",
      "id": "CPAT-0121"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Tic Disorders and Tourette's Disorder",
      "passage_type": "paragraph",
      "passage": "Tic disorders involve sudden, rapid, recurrent, nonrhythmic motor movements or vocalizations. Tics can be simple (eye blinking, throat clearing) or complex (facial gestures, echolalia, coprolalia)",
      "id": "CPAT-0122"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "General Diagnostic Criteria for Personality Disorders",
      "passage_type": "definition",
      "passage": "Key Concept: Ego-Syntonic Nature Personality disorder traits are typically ego-syntonic -- the individual views them as consistent with their self-image and may not recognize them as problematic. This contrasts with most Axis I disorders, where symptoms are ego-dystonic. This ego-syntonic quality often leads to poor insight and resistance to treatment, as individuals may not perceive a need for change",
      "id": "CPAT-0123"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Antisocial Personality Disorder (ASPD)",
      "passage_type": "definition",
      "passage": "ASPD vs. Psychopathy Psychopathy (as measured by Hare's PCL-R) is a related but distinct construct. The PCL-R captures two factors: Factor 1 (interpersonal/affective traits: glibness, grandiosity, lack of empathy, shallow affect) and Factor 2 (antisocial lifestyle: impulsivity, irresponsibility, criminal versatility). Most individuals with psychopathy meet criteria for ASPD, but most individuals with ASPD do not meet criteria for psychopathy (approximately 50-80% of inmates meet ASPD criteria, but only about 15-25% score high on the PCL-R)",
      "id": "CPAT-0124"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Obsessive-Compulsive Personality Disorder (OCPD)",
      "passage_type": "definition",
      "passage": "OCPD vs. OCD OCPD involves ego-syntonic traits -- the person's perfectionism and control feel consistent with who they are. OCD involves ego-dystonic obsessions and compulsions -- the person recognizes them as excessive and distressing. OCPD does not involve true obsessions or compulsions. Despite the name similarity, only about 23-32% of individuals with OCD also have OCPD. OCPD is the most prevalent personality disorder in the general population (approximately 3-8%)",
      "id": "CPAT-0125"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Schizotypal Personality Disorder",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Schizotypal PD has the strongest genetic link to schizophrenia and is considered part of the schizophrenia spectrum . It involves quasi-psychotic symptoms (ideas of reference, magical thinking, perceptual distortions) that fall short of true psychosis. In the ICD-10, schizotypal disorder is classified as a psychotic disorder rather than a personality disorder",
      "id": "CPAT-0126"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Borderline Personality Disorder (BPD)",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Linehan's (1993) biosocial theory proposes that BPD arises from the transaction between biological vulnerability to emotional dysregulation and an invalidating environment (one that erratically, inappropriately, or negligently responds to private experiences). Dialectical Behavior Therapy (DBT) is the best-supported treatment for BPD and targets emotion regulation, distress tolerance, interpersonal effectiveness, and mindfulness. Kernberg's object relations approach emphasizes splitting as the primary defense mechanism in BPD",
      "id": "CPAT-0127"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Paranoid Personality Disorder",
      "passage_type": "example",
      "passage": "Differential Diagnosis Paranoid PD vs. delusional disorder (persecutory type): In paranoid PD, the suspicions are not of delusional intensity -- they are exaggerated interpretations but not fixed, false beliefs. Paranoid PD vs. paranoid schizophrenia: Paranoid PD lacks hallucinations, disorganized speech, and other psychotic features",
      "id": "CPAT-0128"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Narcissistic Personality Disorder",
      "passage_type": "example",
      "passage": "EPPP Example Kohut's self psychology conceptualizes narcissistic pathology as resulting from empathic failures by early caregivers (selfobjects), leading to a fragmented self. Treatment involves providing empathic mirroring and idealizing transferences. Kernberg, in contrast, views narcissistic personality as a pathological grandiose self that defends against underlying aggression and envy, requiring confrontation of defenses in treatment",
      "id": "CPAT-0129"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Evidence-Based Treatments",
      "passage_type": "example",
      "passage": "EPPP Example Mentalization-Based Treatment (MBT) , developed by Bateman and Fonagy, targets the capacity to understand behavior in terms of mental states (thoughts, feelings, intentions). Individuals with BPD show impaired mentalization, particularly under emotional stress, which contributes to interpersonal difficulties. MBT has demonstrated efficacy in reducing self-harm, suicide attempts, and hospitalization in BPD. The concept of mentalization overlaps with but is distinct from theory of mind, empathy, and psychological mindedness",
      "id": "CPAT-0130"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "General Diagnostic Criteria for Personality Disorders",
      "passage_type": "paragraph",
      "passage": "A personality disorder is an enduring pattern of inner experience and behavior that deviates markedly from the expectations of the individual's culture, is pervasive and inflexible, has an onset in adolescence or early adulthood, is stable over time, and leads to distress or impairment. The general criteria require the pattern to be manifested in two or more of the following areas:",
      "id": "CPAT-0131"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "General Diagnostic Criteria for Personality Disorders",
      "passage_type": "paragraph",
      "passage": "The DSM-5 retains the categorical model of 10 personality disorders organized into three clusters, while also including an Alternative DSM-5 Model for Personality Disorders (AMPD) in Section III for further study",
      "id": "CPAT-0132"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Cluster A: Odd or Eccentric",
      "passage_type": "paragraph",
      "passage": "Cluster A personality disorders are characterized by odd, eccentric thinking and behavior. There is a genetic association with schizophrenia spectrum disorders",
      "id": "CPAT-0133"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Paranoid Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of distrust and suspiciousness of others such that their motives are interpreted as malevolent. Features include suspecting exploitation or harm, doubting loyalty of friends, reluctance to confide, reading hidden meanings into benign remarks, bearing grudges, perceiving attacks on character, and recurring suspicions of partner infidelity",
      "id": "CPAT-0134"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Schizoid Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of detachment from social relationships and a restricted range of emotional expression. Features include neither desiring nor enjoying close relationships, choosing solitary activities, little interest in sexual experiences, taking pleasure in few activities, lacking close friends, appearing indifferent to praise or criticism, and emotional coldness or flattened affect",
      "id": "CPAT-0135"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Schizotypal Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of social and interpersonal deficits marked by acute discomfort with close relationships, cognitive or perceptual distortions, and eccentricities of behavior. Features include ideas of reference, odd beliefs or magical thinking, unusual perceptual experiences, odd thinking and speech, suspiciousness, inappropriate or constricted affect, odd behavior or appearance, lack of close friends, and excessive social anxiety that does not diminish with familiarity",
      "id": "CPAT-0136"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Cluster B: Dramatic, Emotional, or Erratic",
      "passage_type": "paragraph",
      "passage": "Cluster B personality disorders involve dramatic, emotional, or erratic behavior. These are among the most frequently tested personality disorders on the EPPP",
      "id": "CPAT-0137"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Antisocial Personality Disorder (ASPD)",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of disregard for and violation of the rights of others , occurring since age 15. The individual must be at least 18 years old, and there must be evidence of conduct disorder before age 15",
      "id": "CPAT-0138"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Borderline Personality Disorder (BPD)",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of instability in interpersonal relationships, self-image, and affects , and marked impulsivity. Five or more of nine criteria are required:",
      "id": "CPAT-0139"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Histrionic Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of excessive emotionality and attention seeking . Features include discomfort when not the center of attention, inappropriately seductive or provocative behavior, shallow and rapidly shifting emotions, use of physical appearance to draw attention, impressionistic speech lacking detail, self-dramatization, suggestibility, and considering relationships more intimate than they are",
      "id": "CPAT-0140"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Narcissistic Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of grandiosity, need for admiration, and lack of empathy . Features include grandiose sense of self-importance, preoccupation with fantasies of success/power/beauty, belief in being special, requiring excessive admiration, sense of entitlement, interpersonal exploitation, lack of empathy, envy of others or belief that others are envious, and arrogant behaviors/attitudes",
      "id": "CPAT-0141"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Cluster C: Anxious or Fearful",
      "passage_type": "paragraph",
      "passage": "Cluster C personality disorders are characterized by anxious and fearful behavior. They share features with anxiety disorders but are distinguished by their pervasiveness and ego-syntonic quality",
      "id": "CPAT-0142"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Avoidant Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation . Features include avoidance of occupational activities involving interpersonal contact due to fear of criticism, unwillingness to get involved unless certain of being liked, restraint in intimate relationships due to shame, preoccupation with rejection in social situations, inhibited in new interpersonal situations, views self as inept/unappealing/inferior, and reluctance to take personal risks or engage in new activities",
      "id": "CPAT-0143"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Dependent Personality Disorder",
      "passage_type": "paragraph",
      "passage": "A pervasive and excessive need to be taken care of that leads to submissive and clinging behavior and fears of separation. Features include difficulty making everyday decisions without advice, needing others to assume responsibility for major life areas, difficulty expressing disagreement, difficulty initiating projects independently, going to excessive lengths to obtain nurturance, feeling uncomfortable or helpless when alone, urgently seeking another relationship when one ends, and unrealistic preoccupation with fears of being left to care for oneself",
      "id": "CPAT-0144"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Obsessive-Compulsive Personality Disorder (OCPD)",
      "passage_type": "paragraph",
      "passage": "A pervasive pattern of preoccupation with orderliness, perfectionism, and mental and interpersonal control , at the expense of flexibility, openness, and efficiency. Features include preoccupation with details/rules/order, perfectionism interfering with task completion, excessive devotion to work, over-conscientiousness about morality, inability to discard worn-out objects, reluctance to delegate, miserly spending style, and rigidity/stubbornness",
      "id": "CPAT-0145"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Alternative DSM-5 Model for Personality Disorders (AMPD)",
      "passage_type": "paragraph",
      "passage": "Section III of the DSM-5 presents an alternative dimensional-categorical hybrid model for personality disorder diagnosis. This model proposes two core criteria:",
      "id": "CPAT-0146"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Criterion B: Pathological Personality Traits",
      "passage_type": "paragraph",
      "passage": "The AMPD retains six specific personality disorders: antisocial, avoidant, borderline, narcissistic, obsessive-compulsive, and schizotypal. The remaining four (paranoid, schizoid, histrionic, dependent) can be described using Criterion A and B but are not retained as named types",
      "id": "CPAT-0147"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Prevalence",
      "passage_type": "paragraph",
      "passage": "The overall prevalence of any personality disorder in the general population is estimated at approximately 9-15% . By cluster:",
      "id": "CPAT-0148"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Course",
      "passage_type": "paragraph",
      "passage": "Longitudinal research has challenged the assumption that personality disorders are stable and unchanging. The Collaborative Longitudinal Personality Disorders Study (CLPS) and other longitudinal studies have shown that many personality disorders improve over time, particularly BPD. Remission rates for BPD are approximately 85% over 10 years, though functional impairment tends to persist even after symptomatic remission",
      "id": "CPAT-0149"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Overview of Schizophrenia Spectrum Disorders",
      "passage_type": "definition",
      "passage": "Spectrum of Psychotic Disorders The DSM-5 arranges psychotic disorders along a gradient: Schizotypal PD (mildest, personality-level), Delusional Disorder , Brief Psychotic Disorder (less than 1 month), Schizophreniform Disorder (1-6 months), Schizophrenia (6+ months), and Schizoaffective Disorder (schizophrenia with a concurrent mood episode). DSM-5 eliminated the classic subtypes (paranoid, disorganized, catatonic, undifferentiated, residual) due to poor diagnostic stability and limited clinical utility",
      "id": "CPAT-0150"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "The Dopamine Hypothesis",
      "passage_type": "definition",
      "passage": "Dopamine Pathways Mesolimbic pathway: Overactivity produces positive symptoms; blocked by antipsychotics to reduce psychosis. Mesocortical pathway: Underactivity produces negative/cognitive symptoms; blocking this pathway worsens these symptoms. Nigrostriatal pathway: Blockade produces extrapyramidal side effects (EPS). Tuberoinfundibular pathway: Blockade increases prolactin (hyperprolactinemia)",
      "id": "CPAT-0151"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "DSM-5 Diagnostic Criteria for Schizophrenia",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl A key DSM-5 change: the special significance previously given to bizarre delusions and Schneiderian first-rank symptoms (e.g., auditory hallucinations of two or more voices conversing) was removed. These no longer allow the single-symptom criterion to be met. Now, at least two Criterion A symptoms are always required, and at least one must be delusions, hallucinations, or disorganized speech",
      "id": "CPAT-0152"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Antipsychotic Medications",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Clozapine is the only antipsychotic with demonstrated superior efficacy for treatment-resistant schizophrenia and is the only medication proven to reduce suicidality in schizophrenia. However, it carries a risk of agranulocytosis (potentially fatal drop in white blood cells) in approximately 1-2% of patients, requiring regular blood monitoring. Clozapine also has significant metabolic and sedative effects",
      "id": "CPAT-0153"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Prognostic Factors",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl The \"rule of thirds\" is a rough prognostic guide: approximately one-third of individuals show significant improvement, one-third show moderate but fluctuating course, and one-third show severe chronic illness. The expressed emotion (EE) literature (Vaughn & Leff, 1976) demonstrates that families high in criticism, hostility, and emotional over-involvement have significantly higher relapse rates, which is the basis for family psychoeducation interventions",
      "id": "CPAT-0154"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Negative Symptoms",
      "passage_type": "example",
      "passage": "EPPP Example Negative symptoms are the strongest predictors of long-term functional outcome in schizophrenia, even more so than positive symptoms. They are associated with structural brain abnormalities (enlarged ventricles, reduced prefrontal cortex volume) and are more characteristic of what was formerly called \"Type II\" or \"deficit\" schizophrenia . Atypical antipsychotics (e.g., clozapine) may have modest benefits for negative symptoms compared to typical antipsychotics",
      "id": "CPAT-0155"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Brief Psychotic Disorder",
      "passage_type": "example",
      "passage": "EPPP Example Duration-based differential diagnosis: Brief Psychotic Disorder = 1 day to less than 1 month. Schizophreniform Disorder = 1 month to less than 6 months. Schizophrenia = 6 months or more (including prodromal/residual symptoms, with at least 1 month of active-phase symptoms). This duration hierarchy is a high-frequency EPPP question",
      "id": "CPAT-0156"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Overview of Schizophrenia Spectrum Disorders",
      "passage_type": "paragraph",
      "passage": "Schizophrenia spectrum and other psychotic disorders are defined by abnormalities in one or more of five domains: delusions, hallucinations, disorganized thinking (speech), grossly disorganized or abnormal motor behavior (including catatonia), and negative symptoms. Schizophrenia is the prototypical psychotic disorder, affecting approximately 1% of the population worldwide with a roughly equal gender distribution, though males tend to have earlier onset and worse prognosis",
      "id": "CPAT-0157"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "DSM-5 Diagnostic Criteria for Schizophrenia",
      "passage_type": "paragraph",
      "passage": "Two or more of the following symptoms, each present for a significant portion of time during a 1-month period (or less if successfully treated). At least one must be (1), (2), or (3):",
      "id": "CPAT-0158"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "DSM-5 Diagnostic Criteria for Schizophrenia",
      "passage_type": "paragraph",
      "passage": "Additional requirements include continuous signs of disturbance for at least 6 months (including at least 1 month of active-phase symptoms), significant functional decline, and exclusion of schizoaffective disorder, mood disorders with psychotic features, substance effects, and medical conditions",
      "id": "CPAT-0159"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Positive Symptoms",
      "passage_type": "paragraph",
      "passage": "Positive symptoms represent an excess or distortion of normal functions. They are the hallmark features of psychosis and tend to respond better to antipsychotic medication",
      "id": "CPAT-0160"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Hallucinations",
      "passage_type": "paragraph",
      "passage": "Hallucinations are perception-like experiences that occur without an external stimulus, are vivid and clear, and are not under voluntary control. Auditory hallucinations are the most common type in schizophrenia, typically experienced as voices that are perceived as distinct from the person's own thoughts. Visual hallucinations, when present, should prompt consideration of medical/neurological causes or substance use",
      "id": "CPAT-0161"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Negative Symptoms",
      "passage_type": "paragraph",
      "passage": "Negative symptoms represent a diminution or loss of normal functions. They are more chronic, more disabling, and less responsive to typical antipsychotic medications than positive symptoms",
      "id": "CPAT-0162"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Cognitive Symptoms",
      "passage_type": "paragraph",
      "passage": "Although not part of the formal diagnostic criteria, cognitive deficits are a core feature of schizophrenia and are present in most individuals with the disorder. They include:",
      "id": "CPAT-0163"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Cognitive Symptoms",
      "passage_type": "paragraph",
      "passage": "Cognitive deficits are present before the onset of psychosis, are relatively stable over the course of illness, and are the strongest predictor of everyday functional capacity . They are poorly addressed by current antipsychotic medications",
      "id": "CPAT-0164"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "The Dopamine Hypothesis",
      "passage_type": "paragraph",
      "passage": "The dopamine hypothesis is the oldest and most influential neurochemical model of schizophrenia. It has evolved through several versions:",
      "id": "CPAT-0165"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "The Glutamate Hypothesis",
      "passage_type": "paragraph",
      "passage": "The glutamate hypothesis proposes that hypofunction of NMDA glutamate receptors contributes to schizophrenia. This is supported by the observation that NMDA receptor antagonists (e.g., PCP, ketamine) produce both positive and negative symptoms that closely mimic schizophrenia. The glutamate model better accounts for negative and cognitive symptoms than the dopamine hypothesis alone",
      "id": "CPAT-0166"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Schizoaffective Disorder",
      "passage_type": "paragraph",
      "passage": "Schizoaffective disorder requires an uninterrupted period of illness during which there is a major mood episode (depressive or manic) concurrent with Criterion A symptoms of schizophrenia. Additionally, delusions or hallucinations must be present for at least 2 weeks in the absence of a major mood episode during the lifetime duration of the illness, and mood episodes must be present for the majority of the total duration of the illness",
      "id": "CPAT-0167"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Delusional Disorder",
      "passage_type": "paragraph",
      "passage": "Delusional disorder involves one or more delusions lasting at least 1 month. Apart from the delusion(s), functioning is not markedly impaired, and behavior is not obviously bizarre. Types include erotomanic, grandiose, jealous, persecutory, somatic, mixed, and unspecified. The key distinction from schizophrenia is the absence of other psychotic symptoms (hallucinations are minimal if present, and there is no disorganized speech, grossly disorganized behavior, or negative symptoms)",
      "id": "CPAT-0168"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Brief Psychotic Disorder",
      "passage_type": "paragraph",
      "passage": "Brief psychotic disorder involves the sudden onset of at least one psychotic symptom (delusions, hallucinations, disorganized speech, or grossly disorganized/catatonic behavior) lasting at least 1 day but less than 1 month , with eventual full return to premorbid functioning. It can be specified as with or without marked stressor(s), or with peripartum onset",
      "id": "CPAT-0169"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Antipsychotic Medications",
      "passage_type": "paragraph",
      "passage": "First-generation (typical) antipsychotics (FGAs: haloperidol, chlorpromazine, fluphenazine) primarily block D2 receptors. They are effective for positive symptoms but can cause significant extrapyramidal side effects (EPS):",
      "id": "CPAT-0170"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Antipsychotic Medications",
      "passage_type": "paragraph",
      "passage": "Second-generation (atypical) antipsychotics (SGAs: clozapine, risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone) have broader receptor profiles (blocking both D2 and 5-HT2A receptors). They have lower EPS risk but greater metabolic side effects (weight gain, diabetes, dyslipidemia)",
      "id": "CPAT-0171"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Overview of Sexual Dysfunctions, Paraphilias, and Gender Dysphoria",
      "passage_type": "definition",
      "passage": "Key DSM-5 Changes DSM-5 made significant changes: sexual dysfunctions were reorganized with gender-specific diagnoses; the distinction between paraphilia (atypical sexual interest, not necessarily a disorder) and paraphilic disorder (a paraphilia causing distress/impairment or harm to others) was clarified; and gender identity disorder was renamed to gender dysphoria to reduce stigmatization and emphasize distress rather than identity as pathological",
      "id": "CPAT-0172"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Orgasmic Disorders",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Masters and Johnson's (1966) Human Sexual Response Cycle (excitement, plateau, orgasm, resolution) and Kaplan's (1979) Triphasic Model (desire, excitement, orgasm) provide the conceptual framework for understanding sexual dysfunctions. DSM-5 moved away from rigid mapping onto these models but they remain foundational for the EPPP. Sensate focus exercises, developed by Masters and Johnson, remain a key behavioral intervention for sexual dysfunctions",
      "id": "CPAT-0173"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Evidence-Based Treatments",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Spectating (Masters & Johnson, 1970) refers to the process whereby an individual monitors and evaluates their own sexual performance during sexual activity, becoming an anxious observer rather than an engaged participant. This self-focused attention creates a negative feedback loop: anxiety impairs sexual response, which increases performance monitoring, which further heightens anxiety. Sensate focus exercises address spectating by redirecting attention to sensory experience and removing performance demands",
      "id": "CPAT-0174"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Criteria in Adolescents and Adults",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl The DSM-5 removal of \"disorder\" from the diagnostic name reflects the movement to depathologize gender diversity. The diagnosis exists primarily to enable access to medical treatment (hormone therapy, surgical interventions) and is distinct from sexual orientation. Research shows that gender dysphoria in childhood persists into adulthood in approximately 12-27% of cases, but persistence rates are much higher when dysphoria intensifies during adolescence",
      "id": "CPAT-0175"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "DSM-5 Paraphilic Disorders",
      "passage_type": "example",
      "passage": "EPPP Example A person with a paraphilia (e.g., fetishism) who does not experience distress, impairment, or harm to others would not meet criteria for a paraphilic disorder. The diagnosis requires either personal distress/impairment (Criterion B for some disorders) or acting on urges with nonconsenting persons (Criterion B for voyeuristic, exhibitionistic, frotteuristic, and pedophilic disorders). This distinction reduces pathologizing of atypical but harmless sexual interests",
      "id": "CPAT-0176"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Nocturnal Penile Tumescence (NPT) Testing",
      "passage_type": "example",
      "passage": "EPPP Example A 45-year-old man reports erectile difficulties with his partner but has morning erections and can achieve erections with masturbation. This pattern is most consistent with situational, psychogenic erectile dysfunction , likely related to performance anxiety or relationship factors. In contrast, a man with no erections in any context (including during sleep) likely has an organic etiology . The lifelong vs. acquired and generalized vs. situational specifiers help guide this differentiation",
      "id": "CPAT-0177"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Overview of Sexual Dysfunctions, Paraphilias, and Gender Dysphoria",
      "passage_type": "paragraph",
      "passage": "The DSM-5 addresses sexual concerns across three separate chapters: Sexual Dysfunctions , Paraphilic Disorders , and Gender Dysphoria . This separation reflects the view that these are fundamentally different types of conditions. Sexual dysfunctions involve disturbances in sexual desire, arousal, or response. Paraphilic disorders involve atypical sexual interests that cause distress or impairment or involve nonconsenting others. Gender dysphoria involves incongruence between experienced/expressed gender and assigned gender",
      "id": "CPAT-0178"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "DSM-5 sexual dysfunctions are gender-specific and generally require a minimum duration of approximately 6 months , occurring on at least 75-100% of sexual occasions, and causing clinically significant distress. Specifiers include lifelong vs. acquired, generalized vs. situational, and current severity",
      "id": "CPAT-0179"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Desire and Arousal Disorders",
      "passage_type": "paragraph",
      "passage": "This new DSM-5 diagnosis combined what DSM-IV separated as hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder. It requires at least 3 of 6 symptoms: absent/reduced interest in sexual activity, absent/reduced sexual fantasies, reduced/absent initiation and unreceptiveness to partner's attempts, absent/reduced sexual excitement during activity, absent/reduced sexual interest in response to internal or external cues, and absent/reduced genital or nongenital sensations during activity",
      "id": "CPAT-0180"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Desire and Arousal Disorders",
      "passage_type": "paragraph",
      "passage": "Persistently or recurrently deficient or absent sexual/erotic thoughts or fantasies and desire for sexual activity. DSM-5 retained this as a separate diagnosis for males, unlike the combined female diagnosis",
      "id": "CPAT-0181"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Desire and Arousal Disorders",
      "passage_type": "paragraph",
      "passage": "Marked difficulty obtaining an erection, maintaining an erection, or marked decrease in erectile rigidity on at least 75-100% of occasions. This is one of the most common sexual dysfunctions in males, particularly with increasing age",
      "id": "CPAT-0182"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Orgasmic Disorders",
      "passage_type": "paragraph",
      "passage": "Marked delay in, marked infrequency of, or absence of orgasm, or markedly reduced intensity of orgasmic sensations on at least 75-100% of occasions",
      "id": "CPAT-0183"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Orgasmic Disorders",
      "passage_type": "paragraph",
      "passage": "Marked delay in ejaculation, or marked infrequency or absence of ejaculation during partnered sexual activity on at least 75-100% of occasions",
      "id": "CPAT-0184"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Orgasmic Disorders",
      "passage_type": "paragraph",
      "passage": "A persistent or recurrent pattern of ejaculation occurring within approximately 1 minute of vaginal penetration and before the individual wishes it. This can also be applied to nonvaginal sexual activities",
      "id": "CPAT-0185"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Sexual Pain Disorders",
      "passage_type": "paragraph",
      "passage": "This new DSM-5 diagnosis combined DSM-IV's vaginismus and dyspareunia into a single diagnosis. It involves persistent or recurrent difficulties with one or more of: vaginal penetration during intercourse, marked vulvovaginal or pelvic pain during intercourse or penetration attempts, marked fear or anxiety about vulvovaginal or pelvic pain in anticipation of or during penetration, and marked tensing or tightening of pelvic floor muscles during attempted penetration. This diagnosis applies only to females",
      "id": "CPAT-0186"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "The DSM-5 makes a crucial distinction: a paraphilia is any intense and persistent sexual interest other than sexual interest in genital stimulation or preparatory fondling with phenotypically normal, physically mature, consenting human partners. A paraphilic disorder is a paraphilia that causes marked distress or impairment, or whose satisfaction requires actions that involve personal harm or risk of harm to others",
      "id": "CPAT-0187"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Gender Dysphoria",
      "passage_type": "paragraph",
      "passage": "Gender dysphoria refers to the distress that may accompany the incongruence between one's experienced or expressed gender and one's assigned gender. DSM-5 renamed this from \"gender identity disorder\" to emphasize that gender nonconformity is not itself a disorder -- the clinical problem is the distress (dysphoria) that may accompany it",
      "id": "CPAT-0188"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Criteria in Children",
      "passage_type": "paragraph",
      "passage": "Requires at least 6 of 8 criteria over at least 6 months, including a strong desire to be of the other gender or insistence that one is the other gender (or some alternative gender). Other criteria include strong preference for cross-gender roles in play, toys, and activities; strong preference for playmates of the other gender; strong rejection of typically gendered toys/activities; strong dislike of one's sexual anatomy; and strong desire for primary/secondary sex characteristics matching experienced gender",
      "id": "CPAT-0189"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Criteria in Adolescents and Adults",
      "passage_type": "paragraph",
      "passage": "Requires at least 2 of 6 criteria over at least 6 months: marked incongruence between experienced/expressed gender and primary/secondary sex characteristics, strong desire to be rid of one's sex characteristics, strong desire for sex characteristics of the other gender, strong desire to be the other gender, strong desire to be treated as the other gender, and strong conviction that one has the typical feelings and reactions of the other gender",
      "id": "CPAT-0190"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Nocturnal Penile Tumescence (NPT) Testing",
      "passage_type": "paragraph",
      "passage": "NPT testing measures erections during sleep. Normal NPT in a man with erectile complaints suggests a psychogenic etiology (performance anxiety, depression, relationship issues), while absent NPT suggests an organic cause (vascular, neurological, hormonal). This distinction guides treatment planning -- psychogenic erectile dysfunction responds well to psychotherapy, while organic erectile dysfunction requires medical intervention",
      "id": "CPAT-0191"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Overview of Substance-Related and Addictive Disorders",
      "passage_type": "definition",
      "passage": "DSM-5 Substance Use Disorder Criteria A problematic pattern of substance use leading to clinically significant impairment or distress, manifested by at least 2 of 11 criteria within a 12-month period. Severity: Mild (2-3 criteria), Moderate (4-5 criteria), Severe (6+ criteria). The 11 criteria cluster into four groups: impaired control, social impairment, risky use, and pharmacological criteria",
      "id": "CPAT-0192"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Alcohol Withdrawal",
      "passage_type": "definition",
      "passage": "Delirium Tremens (DTs) Delirium tremens is the most severe form of alcohol withdrawal, occurring in approximately 5% of individuals undergoing withdrawal, typically 48-72 hours after the last drink. Features include profound confusion, vivid hallucinations (often visual -- classically insects or small animals), autonomic instability, agitation, and fever. DTs carry a mortality rate of up to 5% without treatment. Treatment involves benzodiazepines (especially long-acting agents like chlordiazepoxide or diazepam)",
      "id": "CPAT-0193"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Tolerance, Dependence, and Key Concepts",
      "passage_type": "definition",
      "passage": "Tolerance vs. Dependence vs. Addiction Tolerance: Needing more of a substance to achieve the same effect, or diminished effect with the same amount. Physical dependence: A physiological state in which withdrawal symptoms occur upon cessation; can occur with appropriate medical use and does not necessarily indicate a SUD. Addiction (SUD): A behavioral pattern of compulsive substance use despite adverse consequences, involving impaired control, social impairment, and risky use. The DSM-5 avoids the term \"addiction\" in diagnostic labels to reduce stigma",
      "id": "CPAT-0194"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "definition",
      "passage": "Parallels with Substance Use Disorders The diagnostic criteria for gambling disorder closely parallel the 11 SUD criteria , including tolerance (needing more to achieve excitement), withdrawal (restlessness when stopping), loss of control, and continued engagement despite negative consequences. This parallel is deliberate and reflects the shared underlying pathology",
      "id": "CPAT-0195"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Pharmacological Criteria (Criteria 10-11)",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Tolerance and withdrawal are neither necessary nor sufficient for an SUD diagnosis. A person taking prescribed opioids after surgery may develop tolerance and withdrawal but would not necessarily have an SUD. Conversely, a person can meet criteria for SUD (e.g., 2-3 social/behavioral criteria) without exhibiting tolerance or withdrawal. The DSM-5 notes that tolerance and withdrawal criteria should not be counted when substances are taken solely under appropriate medical supervision",
      "id": "CPAT-0196"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Naloxone (Narcan)",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Good Samaritan laws have been enacted in most U.S. states to encourage bystanders to call emergency services and administer naloxone during an overdose without fear of legal prosecution for drug-related offenses. These laws are an important public health tool in the opioid epidemic. Psychologists should be familiar with naloxone access and Good Samaritan protections in their jurisdiction",
      "id": "CPAT-0197"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Stages of Change Model",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Motivational interviewing (MI) (Miller & Rollnick, 2013) is the therapeutic approach most closely aligned with the stages of change model. MI uses a collaborative, empathic, non-confrontational approach to strengthen a person's own motivation for change. Core principles include expressing empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy. The OARS technique (Open questions, Affirmations, Reflections, Summaries) is fundamental to MI practice",
      "id": "CPAT-0198"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Opioid Withdrawal",
      "passage_type": "example",
      "passage": "EPPP Example Pharmacological treatments for opioid use disorder: Methadone (full mu-opioid agonist; reduces cravings and withdrawal; dispensed through certified clinics). Buprenorphine (partial mu-opioid agonist; lower abuse potential than methadone; can be prescribed in office settings; often combined with naloxone as Suboxone). Naltrexone (opioid antagonist; blocks euphoric effects; available as daily oral or monthly injectable [Vivitrol]; requires full detoxification before initiation to avoid precipitated withdrawal)",
      "id": "CPAT-0199"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Neuroadaptation and Allostasis",
      "passage_type": "example",
      "passage": "EPPP Example The opponent-process theory (Solomon & Corbit, 1974) explains drug tolerance and withdrawal through opposing emotional processes. The initial positive effect (a-process) triggers a compensatory negative effect (b-process). With repeated use, the b-process strengthens, requiring more substance to achieve the same positive effect (tolerance) and producing a powerful negative state when the substance is absent (withdrawal). This model applies beyond substance use to understanding any habituation to emotional stimuli",
      "id": "CPAT-0200"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Prevalence and Clinical Features",
      "passage_type": "example",
      "passage": "EPPP Example Internet gaming disorder was not included as an official DSM-5 diagnosis but was placed in Section III (\"Conditions for Further Study\"). Gambling disorder remains the only recognized behavioral addiction in the DSM-5. The decision to include gambling disorder was based on decades of evidence showing that it parallels substance addiction in clinical presentation, comorbidity, neurobiology, physiology, and treatment response",
      "id": "CPAT-0201"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Overview of Substance-Related and Addictive Disorders",
      "passage_type": "paragraph",
      "passage": "The DSM-5 made significant changes to the diagnosis of substance-related disorders. The most notable change was the elimination of the abuse/dependence distinction from DSM-IV, replacing it with a single substance use disorder (SUD) diagnosis on a continuum of severity. The DSM-5 also added gambling disorder as the first non-substance behavioral addiction and removed the legal problems criterion while adding craving",
      "id": "CPAT-0202"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Alcohol Use Disorder",
      "passage_type": "paragraph",
      "passage": "Alcohol use disorder (AUD) is the most commonly diagnosed SUD. Lifetime prevalence in the United States is approximately 29% . Genetic factors account for approximately 50-60% of the variance in risk for AUD",
      "id": "CPAT-0203"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Alcohol Withdrawal",
      "passage_type": "paragraph",
      "passage": "Alcohol withdrawal occurs after cessation or reduction of heavy, prolonged use. Symptoms begin within 6-24 hours after the last drink and can include:",
      "id": "CPAT-0204"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Opioid Use Disorder",
      "passage_type": "paragraph",
      "passage": "Opioid use disorder involves problematic use of opioids (heroin, prescription painkillers such as oxycodone, hydrocodone, fentanyl, or morphine). Opioids act on mu, delta, and kappa receptors, with mu receptor activation producing analgesia, euphoria, respiratory depression, and physical dependence",
      "id": "CPAT-0205"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Opioid Withdrawal",
      "passage_type": "paragraph",
      "passage": "Opioid withdrawal is intensely uncomfortable but generally not life-threatening (unlike alcohol or benzodiazepine withdrawal). Symptoms emerge within hours of last use and include:",
      "id": "CPAT-0206"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Opioid Overdose Management",
      "passage_type": "paragraph",
      "passage": "Opioid overdose is a life-threatening medical emergency. Recognition and rapid intervention are critical topics for clinical practice and the EPPP",
      "id": "CPAT-0207"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Naloxone (Narcan)",
      "passage_type": "paragraph",
      "passage": "Naloxone (brand name Narcan) is a pure opioid antagonist that rapidly reverses the effects of opioid overdose by competitively binding to mu-opioid receptors, displacing the opioid. Key clinical features include:",
      "id": "CPAT-0208"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Cannabis Use Disorder",
      "passage_type": "paragraph",
      "passage": "Cannabis use disorder is recognized in DSM-5 with the same 11-criterion framework. Cannabis withdrawal is now an official diagnosis in DSM-5, occurring within approximately 1 week of cessation of heavy use. Symptoms include irritability/anger, nervousness/anxiety, sleep difficulty, decreased appetite/weight loss, restlessness, depressed mood, and at least one physical symptom (abdominal pain, shakiness, sweating, fever, chills, headache)",
      "id": "CPAT-0209"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Stimulant Use Disorder",
      "passage_type": "paragraph",
      "passage": "Includes cocaine, amphetamines, and other stimulant-type substances. Stimulants increase dopamine in the mesolimbic reward pathway. Stimulant withdrawal (\"crash\") is characterized by dysphoric mood, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite, and psychomotor retardation or agitation",
      "id": "CPAT-0210"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Cross-Tolerance and Cross-Dependence",
      "passage_type": "paragraph",
      "passage": "Cross-tolerance occurs when tolerance to one substance extends to another substance within the same pharmacological class (e.g., alcohol and benzodiazepines, both of which act on GABA-A receptors). Cross-dependence is when one substance can suppress withdrawal symptoms from another substance in the same class, which is the basis for using benzodiazepines to manage alcohol withdrawal",
      "id": "CPAT-0211"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Neurobiology of Addiction",
      "passage_type": "paragraph",
      "passage": "Understanding the neurobiological basis of addiction is essential for the EPPP. The brain's reward system is central to addiction:",
      "id": "CPAT-0212"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "The Mesolimbic Dopamine Pathway",
      "passage_type": "paragraph",
      "passage": "The mesolimbic dopamine pathway (ventral tegmental area to nucleus accumbens) is the primary neural circuit involved in reward and reinforcement. All substances of abuse, despite their different mechanisms of action, ultimately increase dopamine transmission in the nucleus accumbens. This \"final common pathway\" explains why diverse substances can all produce addiction (Koob & Volkow, 2016)",
      "id": "CPAT-0213"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Neuroadaptation and Allostasis",
      "passage_type": "paragraph",
      "passage": "With chronic substance use, the brain undergoes neuroadaptation : the reward system becomes downregulated (fewer dopamine receptors, reduced dopamine release), leading to tolerance and a new hedonic set point. Koob's allostatic model proposes that addiction involves a shift from positive reinforcement (seeking pleasure) to negative reinforcement (avoiding withdrawal and dysphoria). The extended amygdala and stress systems (CRF, norepinephrine) become hyperactivated, driving the compulsive drug-seeking characteristic of addiction",
      "id": "CPAT-0214"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Stages of Change Model",
      "passage_type": "paragraph",
      "passage": "Prochaska and DiClemente's (1983) Transtheoretical Model (Stages of Change) is widely used in substance use treatment and is a commonly tested EPPP topic",
      "id": "CPAT-0215"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Gambling Disorder",
      "passage_type": "paragraph",
      "passage": "Gambling disorder is the first and only non-substance behavioral addiction included in the DSM-5, placed in the Substance-Related and Addictive Disorders chapter. This placement reflects growing evidence that gambling disorder shares significant neurobiological, genetic, and clinical features with substance use disorders",
      "id": "CPAT-0216"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Persistent and recurrent problematic gambling behavior leading to clinically significant impairment or distress, as indicated by 4 or more of 9 criteria within a 12-month period :",
      "id": "CPAT-0217"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Neurobiology",
      "passage_type": "paragraph",
      "passage": "Neuroimaging and neuropharmacological studies have demonstrated that gambling disorder shares key neurobiological features with substance addiction. The dopamine reward system -- particularly the mesolimbic pathway from the ventral tegmental area to the nucleus accumbens -- is activated during gambling in ways that closely parallel activation seen with substance use. Individuals with gambling disorder show reduced striatal dopamine receptor availability, impaired prefrontal cortex function (contributing to poor decision-making), and heightened responsivity to gambling-related cues",
      "id": "CPAT-0218"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Prevalence and Clinical Features",
      "passage_type": "paragraph",
      "passage": "Prevalence of gambling disorder is estimated at 0.4-1% of adults . Males are affected more frequently than females, though the gender gap is narrowing. Gambling disorder has high comorbidity with substance use disorders, mood disorders, and personality disorders (particularly antisocial personality disorder). Severity specifiers follow the SUD model: mild (4-5 criteria), moderate (6-7 criteria), severe (8-9 criteria)",
      "id": "CPAT-0219"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Overview of Trauma- and Stressor-Related Disorders",
      "passage_type": "definition",
      "passage": "Key DSM-5 Change PTSD is no longer classified as an anxiety disorder. The DSM-5 reorganization places it alongside acute stress disorder, adjustment disorders, reactive attachment disorder, and disinhibited social engagement disorder in a chapter unified by the requirement of an identifiable stressor as an etiological criterion",
      "id": "CPAT-0220"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "DSM-5-TR Diagnostic Criteria",
      "passage_type": "definition",
      "passage": "Distinction from Normal Grief Normal grief is a natural response to loss that, while painful, typically decreases in intensity over time as the bereaved individual adapts. In prolonged grief disorder, the grief response does not diminish over time and remains at an intensity that causes significant distress and functional impairment well beyond expected norms. The duration and severity must cause clinically significant impairment in social, occupational, or other important areas of functioning",
      "id": "CPAT-0221"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "The Four Symptom Clusters",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Major DSM-5 changes to PTSD: (1) Moved from anxiety disorders to its own chapter. (2) Criterion A was tightened -- subjective response of fear/helplessness/horror was removed. (3) Expanded from 3 to 4 symptom clusters (avoidance and numbing were separated). (4) Added \"with dissociative symptoms\" specifier (depersonalization or derealization). (5) Added \"with delayed expression\" specifier (full criteria not met until at least 6 months after the event, though some symptoms may begin immediately). (6) Added reckless/self-destructive behavior and negative cognitions as symptoms",
      "id": "CPAT-0222"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Prevalence and Treatment",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl PGD is distinct from MDD and PTSD. While grief may include depressive symptoms, PGD is specifically focused on the loss of the deceased and the yearning/preoccupation that follows. The 12-month (adults) and 6-month (children) duration thresholds help ensure the diagnosis is not applied to normal grief. The grief response must also exceed expected social, cultural, and religious norms for the individual's context",
      "id": "CPAT-0223"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Dissociative Identity Disorder (DID)",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl DID is controversial. The posttraumatic model views DID as arising from severe childhood trauma (typically severe physical/sexual abuse before age 9), with dissociation serving as a defense mechanism. The sociocognitive model  argues that DID is created through therapist suggestion, media influences, and sociocultural expectations, noting that it was rarely diagnosed before the 1980s and that its prevalence increased dramatically after media portrayals. Most research supports an association with childhood trauma, but the debate continues",
      "id": "CPAT-0224"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "clinical_note",
      "passage": "Clinical Pearl Psychological debriefing (including Critical Incident Stress Debriefing/CISD) -- single-session interventions provided immediately after trauma -- has been shown in multiple studies and meta-analyses to be ineffective and potentially harmful , as it may impede natural recovery processes . Current guidelines recommend against mandatory debriefing. Instead, evidence supports psychological first aid -- a non-intrusive, practical approach focused on safety, calming, self-efficacy, social connectedness, and hope",
      "id": "CPAT-0225"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Acute Stress Disorder",
      "passage_type": "example",
      "passage": "EPPP Example Key distinction: ASD = 3 days to 1 month post-trauma. PTSD = symptoms persisting for more than 1 month . If PTSD criteria are not met until at least 6 months after the event, specify \"with delayed expression.\" Approximately 50% of individuals who develop PTSD initially present with ASD, but not all individuals with ASD go on to develop PTSD",
      "id": "CPAT-0226"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Conversion Disorder (Functional Neurological Symptom Disorder)",
      "passage_type": "example",
      "passage": "EPPP Example La belle indifference (a relative lack of concern about the nature or implications of the symptom) was historically associated with conversion disorder, but research has shown it is neither sensitive nor specific for the diagnosis. It should not be used as a reliable diagnostic indicator. Hoover's sign and other clinical tests of internal inconsistency are more useful for establishing the \"incompatibility\" criterion in DSM-5",
      "id": "CPAT-0227"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Overview of Trauma- and Stressor-Related Disorders",
      "passage_type": "paragraph",
      "passage": "The DSM-5 created a new chapter for trauma- and stressor-related disorders , removing PTSD and acute stress disorder from the anxiety disorders chapter. This change reflects the recognition that the response to traumatic events is not limited to anxiety-based symptoms but also includes anhedonic/dysphoric, externalizing (anger, aggression), and dissociative presentations. The common element is exposure to a traumatic or stressful event as a diagnostic criterion",
      "id": "CPAT-0228"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Posttraumatic Stress Disorder (PTSD)",
      "passage_type": "paragraph",
      "passage": "PTSD is the most commonly tested trauma-related disorder on the EPPP. DSM-5 made several important changes to the diagnostic criteria, expanding from three to four symptom clusters",
      "id": "CPAT-0229"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "The Four Symptom Clusters",
      "passage_type": "paragraph",
      "passage": "Duration must be more than 1 month . Prevalence is approximately 6.8% lifetime in the United States, with women approximately twice as likely as men to develop PTSD. The strongest predictor of PTSD development is peritraumatic dissociation -- dissociative experiences during or immediately after the traumatic event",
      "id": "CPAT-0230"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Acute Stress Disorder",
      "passage_type": "paragraph",
      "passage": "Acute stress disorder (ASD) shares similar symptomatology with PTSD but differs in its time course. ASD occurs within 3 days to 1 month after trauma exposure and requires 9 or more symptoms from any of five categories: intrusion, negative mood, dissociation, avoidance, and arousal",
      "id": "CPAT-0231"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Adjustment Disorders",
      "passage_type": "paragraph",
      "passage": "Adjustment disorders involve the development of emotional or behavioral symptoms in response to an identifiable stressor occurring within 3 months of the onset of the stressor. Symptoms must be clinically significant (out of proportion to the stressor or causing significant impairment) and must resolve within 6 months of the termination of the stressor",
      "id": "CPAT-0232"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Prolonged Grief Disorder",
      "passage_type": "paragraph",
      "passage": "Prolonged Grief Disorder (PGD) was added to the DSM-5-TR (2022) as a new diagnosis within the trauma- and stressor-related disorders chapter. It is characterized by a persistent and pervasive grief response following the death of someone close that exceeds expected social, cultural, or religious norms in both duration and intensity",
      "id": "CPAT-0233"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "DSM-5-TR Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "The death of someone close to the individual must have occurred at least 12 months ago for adults, or at least 6 months ago for children and adolescents. Since the death, the individual has experienced, on more days than not, one or both of:",
      "id": "CPAT-0234"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "DSM-5-TR Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "In addition, at least 3 of the following 8 symptoms must be present most days, to a clinically significant degree, since the death:",
      "id": "CPAT-0235"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Prevalence and Treatment",
      "passage_type": "paragraph",
      "passage": "Approximately 10% of bereaved individuals develop prolonged grief disorder. Risk factors include close kinship to the deceased (e.g., loss of a spouse or child), sudden or violent death, prior psychiatric history, and insecure attachment style",
      "id": "CPAT-0236"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Prevalence and Treatment",
      "passage_type": "paragraph",
      "passage": "The most well-supported treatment is Complicated Grief Treatment (CGT) , developed by M. Katherine Shear. CGT is a 16-session protocol that combines elements of interpersonal therapy (IPT) and exposure-based techniques . It includes revisiting the story of the death (imaginal exposure), situational exposure to avoided reminders, and work on restoring functioning and pursuing personal goals. CGT has been shown to be more effective than standard interpersonal psychotherapy for this condition",
      "id": "CPAT-0237"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Dissociative Disorders",
      "passage_type": "paragraph",
      "passage": "Dissociative disorders involve disruptions in the normally integrated functions of consciousness, memory, identity, emotion, perception, behavior, and sense of self. They are placed after the trauma chapter in DSM-5 to reflect their close relationship with traumatic experiences",
      "id": "CPAT-0238"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Dissociative Identity Disorder (DID)",
      "passage_type": "paragraph",
      "passage": "Dissociative Identity Disorder (formerly multiple personality disorder) involves a disruption of identity characterized by two or more distinct personality states or an experience of possession, with marked discontinuity in sense of self and sense of agency. Associated features include:",
      "id": "CPAT-0239"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Depersonalization/Derealization Disorder",
      "passage_type": "paragraph",
      "passage": "Depersonalization involves persistent or recurrent experiences of unreality, detachment, or being an outside observer with respect to one's thoughts, feelings, body, or actions (e.g., feeling like a robot, dreamlike state, sense of unreality of self). Derealization involves experiences of unreality or detachment with respect to surroundings (e.g., the world seems unreal, dreamlike, distant, or distorted). Crucially, reality testing remains intact -- the individual knows the experiences are not real",
      "id": "CPAT-0240"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Dissociative Amnesia",
      "passage_type": "paragraph",
      "passage": "Dissociative amnesia involves an inability to recall important autobiographical information, usually of a traumatic or stressful nature, that is inconsistent with ordinary forgetting. It may be localized (specific event/time period), selective (some aspects of an event), or generalized (identity and life history). The specifier \"with dissociative fugue\" applies when the individual engages in purposeful travel or bewildered wandering associated with amnesia for identity or other important autobiographical information",
      "id": "CPAT-0241"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Somatic Symptom and Related Disorders",
      "passage_type": "paragraph",
      "passage": "Though in a separate DSM-5 chapter, somatic symptom disorders are frequently tested alongside trauma and dissociative conditions",
      "id": "CPAT-0242"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Somatic Symptom Disorder",
      "passage_type": "paragraph",
      "passage": "Somatic symptom disorder replaced DSM-IV's somatization disorder and is defined by one or more somatic symptoms that are distressing or result in significant disruption of daily life, accompanied by excessive thoughts, feelings, or behaviors related to the somatic symptoms. Importantly, the DSM-5 no longer requires that symptoms be \"medically unexplained\" -- the focus is on the disproportionate response to symptoms",
      "id": "CPAT-0243"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Illness Anxiety Disorder",
      "passage_type": "paragraph",
      "passage": "Illness anxiety disorder (replacing DSM-IV's hypochondriasis, in part) involves preoccupation with having or acquiring a serious illness, with minimal or no somatic symptoms present. If somatic symptoms are present, the anxiety about illness is clearly disproportionate. The individual has high health anxiety and performs excessive health-related behaviors or shows maladaptive avoidance",
      "id": "CPAT-0244"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Conversion Disorder (Functional Neurological Symptom Disorder)",
      "passage_type": "paragraph",
      "passage": "Conversion disorder involves one or more symptoms of altered voluntary motor or sensory function, with clinical findings providing evidence of incompatibility between the symptom and recognized neurological or medical conditions. DSM-5 removed the requirement to demonstrate a psychological stressor and renamed it to include \"functional neurological symptom disorder.\"",
      "id": "CPAT-0245"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Factitious Disorder",
      "passage_type": "paragraph",
      "passage": "Factitious disorder involves falsification of medical or psychological symptoms or induction of injury/disease, in the absence of obvious external rewards. The deception is present even when external incentives are absent. Factitious disorder imposed on self (formerly Munchausen syndrome) and factitious disorder imposed on another (formerly Munchausen by proxy) are both recognized. Unlike malingering (which involves external incentives), factitious disorder is driven by the motivation to assume the sick role",
      "id": "CPAT-0246"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion A: Excessive anxiety and worry occurring more days than not for at least 6 months, about a number of events or activities.",
      "id": "CPAT-0247"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: The anxiety and worry are associated with three or more of the following (only one required in children): restlessness or feeling keyed up, being easily fatigued, difficulty concentrating or mind going blank, irritability, muscle tension, sleep disturbance.",
      "id": "CPAT-0248"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion D: The disturbance causes clinically significant distress or impairment.",
      "id": "CPAT-0249"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Specific Phobias",
      "passage_type": "paragraph",
      "passage": "Blood-injection-injury (BII) type -- uniquely associated with a vasovagal response (fainting)",
      "id": "CPAT-0250"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Biological Models",
      "passage_type": "paragraph",
      "passage": "Neurotransmitters: Dysregulation of GABA (inhibitory), serotonin (5-HT), and norepinephrine is implicated across anxiety disorders. OCD is particularly linked to serotonin dysfunction, supported by the efficacy of SSRIs and clomipramine (a serotonergic TCA).",
      "id": "CPAT-0251"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Biological Models",
      "passage_type": "paragraph",
      "passage": "Neuroanatomy: The amygdala plays a central role in fear conditioning. The cortico-striato-thalamo-cortical (CSTC) circuit is implicated in OCD. Hyperactivity in the orbitofrontal cortex and caudate nucleus is a consistent finding in neuroimaging studies of OCD (Saxena et al., 1998).",
      "id": "CPAT-0252"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Biological Models",
      "passage_type": "paragraph",
      "passage": "Genetics: Heritability estimates for anxiety disorders range from 30-50%. First-degree relatives of individuals with OCD have a 4-5 times increased risk of developing OCD.",
      "id": "CPAT-0253"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Cognitive Models",
      "passage_type": "paragraph",
      "passage": "Attentional bias: Individuals with anxiety disorders show preferential attention to threat-related stimuli (MacLeod et al., 1986).",
      "id": "CPAT-0254"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Cognitive Models",
      "passage_type": "paragraph",
      "passage": "Catastrophic misinterpretation: Clark's (1986) model of panic; Wells' (1995) metacognitive model of GAD.",
      "id": "CPAT-0255"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Cognitive Models",
      "passage_type": "paragraph",
      "passage": "Inflated responsibility: Salkovskis (1985) proposed that OCD arises from the belief that one has the power and duty to prevent harm, leading to neutralizing compulsions.",
      "id": "CPAT-0256"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Cognitive Models",
      "passage_type": "paragraph",
      "passage": "Thought-action fusion: The belief that thinking about an action is morally equivalent to performing it, or that thinking about an event makes it more likely to occur (Rachman, 1993).",
      "id": "CPAT-0257"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Psychotherapy",
      "passage_type": "paragraph",
      "passage": "Exposure and Response Prevention (ERP): The gold-standard treatment for OCD. Involves systematic exposure to feared stimuli (obsession triggers) while preventing the compulsive response. Approximately 60-70% of patients show significant improvement. Based on the principle that anxiety habituates with prolonged exposure and that preventing compulsions breaks the negative reinforcement cycle.",
      "id": "CPAT-0258"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Psychotherapy",
      "passage_type": "paragraph",
      "passage": "Cognitive-Behavioral Therapy (CBT): First-line treatment for all anxiety disorders. For GAD, targets intolerance of uncertainty and worry beliefs. For social anxiety, involves cognitive restructuring of negative self-evaluations and behavioral experiments with video feedback. For panic disorder, involves interoceptive exposure (deliberately producing feared bodily sensations) and cognitive restructuring of catastrophic misinterpretations.",
      "id": "CPAT-0259"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Psychotherapy",
      "passage_type": "paragraph",
      "passage": "Acceptance and Commitment Therapy (ACT): Emerging evidence for anxiety disorders; emphasizes psychological flexibility, acceptance of internal experiences, and values-based action rather than symptom elimination.",
      "id": "CPAT-0260"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Psychotherapy",
      "passage_type": "paragraph",
      "passage": "Applied relaxation: Ost's method teaching rapid relaxation skills; effective for GAD.",
      "id": "CPAT-0261"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "SSRIs: First-line pharmacological treatment for all anxiety disorders and OCD. Higher doses are typically needed for OCD (e.g., fluoxetine 60-80 mg) compared to depression (20 mg). Onset of therapeutic effect is 4-6 weeks for anxiety, and up to 8-12 weeks for OCD.",
      "id": "CPAT-0262"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "SNRIs: Venlafaxine and duloxetine are effective for GAD and social anxiety disorder.",
      "id": "CPAT-0263"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Benzodiazepines: Effective for acute anxiety relief but not recommended as first-line treatment due to risk of dependence, tolerance, and withdrawal. They do not treat OCD.",
      "id": "CPAT-0264"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Clomipramine: A serotonergic TCA that is effective for OCD, sometimes used when SSRIs fail. Has more side effects than SSRIs.",
      "id": "CPAT-0265"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Buspirone: A 5-HT1A partial agonist used for GAD; slow onset (2-4 weeks); no abuse potential; not effective for OCD or panic.",
      "id": "CPAT-0266"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion A: Developmentally inappropriate and excessive fear or anxiety concerning separation from those to whom the individual is attached, as evidenced by at least three of the following: Recurrent excessive distress when anticipating or experiencing separation from home or major attachment figures Persistent and excessive worry about losing major attachment figures or about possible harm to them (e.g., illness, injury, disaster, death) Persistent and excessive worry about experiencing an untoward event (e.g., getting lost, being kidnapped, having an accident) that causes separation from a major attachment figure Persistent reluctance or refusal to go out, away from home, to school, to work, or elsewhere because of fear of separation Persistent and excessive fear of or reluctance about being alone or without major attachment figures at home or in other settings Persistent reluctance or refusal to sleep away from home or to go to sleep without being near a major attachment figure Repeated nightmares involving the theme of separation Repeated complaints of physical symptoms (e.g., headaches, stomachaches, nausea, vomiting) when separation from major attachment figures occurs or is anticipated",
      "id": "CPAT-0267"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Recurrent excessive distress when anticipating or experiencing separation from home or major attachment figures",
      "id": "CPAT-0268"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Persistent and excessive worry about losing major attachment figures or about possible harm to them (e.g., illness, injury, disaster, death)",
      "id": "CPAT-0269"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Persistent and excessive worry about experiencing an untoward event (e.g., getting lost, being kidnapped, having an accident) that causes separation from a major attachment figure",
      "id": "CPAT-0270"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Persistent reluctance or refusal to go out, away from home, to school, to work, or elsewhere because of fear of separation",
      "id": "CPAT-0271"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Persistent and excessive fear of or reluctance about being alone or without major attachment figures at home or in other settings",
      "id": "CPAT-0272"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Persistent reluctance or refusal to sleep away from home or to go to sleep without being near a major attachment figure",
      "id": "CPAT-0273"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Repeated complaints of physical symptoms (e.g., headaches, stomachaches, nausea, vomiting) when separation from major attachment figures occurs or is anticipated",
      "id": "CPAT-0274"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion B: The fear, anxiety, or avoidance is persistent, lasting at least 4 weeks in children and adolescents and typically 6 months or more in adults.",
      "id": "CPAT-0275"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: The disturbance causes clinically significant distress or impairment in social, academic, occupational, or other important areas of functioning.",
      "id": "CPAT-0276"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion D: The disturbance is not better explained by another mental disorder.",
      "id": "CPAT-0277"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion A: Preoccupation with one or more perceived defects or flaws in physical appearance that are not observable or appear only slight to others.",
      "id": "CPAT-0278"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion B: At some point during the course of the disorder, the individual has performed repetitive behaviors (e.g., mirror checking, excessive grooming, skin picking, reassurance seeking) or mental acts (e.g., comparing his or her appearance with that of others) in response to the appearance concerns.",
      "id": "CPAT-0279"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: The preoccupation causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.",
      "id": "CPAT-0280"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion D: The appearance preoccupation is not better explained by concerns with body fat or weight in an individual whose symptoms meet diagnostic criteria for an eating disorder.",
      "id": "CPAT-0281"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "paragraph",
      "passage": "With muscle dysmorphia: The individual is preoccupied with the idea that his or her body build is too small or insufficiently muscular. This specifier applies even if the individual is also preoccupied with other body areas.",
      "id": "CPAT-0282"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "paragraph",
      "passage": "Insight specifier: With good or fair insight, with poor insight, or with absent insight/delusional beliefs.",
      "id": "CPAT-0283"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion A: Persistent difficulty discarding or parting with possessions, regardless of their actual value.",
      "id": "CPAT-0284"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion B: This difficulty is due to a perceived need to save the items and to distress associated with discarding them.",
      "id": "CPAT-0285"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: The difficulty discarding possessions results in the accumulation of possessions that congest and clutter active living areas and substantially compromises their intended use. If living areas are uncluttered, it is only because of the interventions of third parties (e.g., family members, cleaners, authorities).",
      "id": "CPAT-0286"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion D: The hoarding causes clinically significant distress or impairment in social, occupational, or other important areas of functioning (including maintaining a safe environment for oneself or others).",
      "id": "CPAT-0287"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion E: The hoarding is not attributable to another medical condition (e.g., brain injury, cerebrovascular disease, Prader-Willi syndrome).",
      "id": "CPAT-0288"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion F: The hoarding is not better explained by the symptoms of another mental disorder.",
      "id": "CPAT-0289"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Specifiers",
      "passage_type": "paragraph",
      "passage": "With excessive acquisition: If difficulty discarding possessions is accompanied by excessive acquiring of items that are not needed or for which there is no available space.",
      "id": "CPAT-0290"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: The hair pulling causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.",
      "id": "CPAT-0291"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion D: The hair pulling or hair loss is not attributable to another medical condition (e.g., a dermatological condition).",
      "id": "CPAT-0292"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion E: The hair pulling is not better explained by the symptoms of another mental disorder (e.g., attempts to improve a perceived defect in appearance in BDD).",
      "id": "CPAT-0293"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: The skin picking causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.",
      "id": "CPAT-0294"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion D: The skin picking is not attributable to the physiological effects of a substance (e.g., cocaine) or another medical condition (e.g., scabies).",
      "id": "CPAT-0295"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion E: The skin picking is not better explained by symptoms of another mental disorder (e.g., delusions or tactile hallucinations in psychotic disorder, attempts to improve perceived defect in BDD, stereotypies in stereotypic movement disorder, intention to harm oneself in nonsuicidal self-injury).",
      "id": "CPAT-0296"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "GAD requires worry on more days than not for at least 6 months plus 3+ associated symptoms (only 1 for children)",
      "id": "CPAT-0297"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "BII phobia is unique among phobias for its vasovagal/fainting response; treated with applied tension, not relaxation",
      "id": "CPAT-0298"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Panic attacks are a specifier in DSM-5, not a separate disorder -- they can occur across multiple disorders",
      "id": "CPAT-0299"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Mowrer's two-factor theory: classical conditioning acquires fear; operant conditioning (negative reinforcement) maintains avoidance",
      "id": "CPAT-0300"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "The CSTC circuit (orbitofrontal cortex, caudate, thalamus) is the key neural pathway in OCD",
      "id": "CPAT-0301"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "SSRIs are first-line pharmacotherapy for all anxiety disorders and OCD; higher doses are typically needed for OCD",
      "id": "CPAT-0302"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Separation anxiety disorder was moved from childhood-onset disorders to the anxiety chapter in DSM-5; can be diagnosed in adults (6-month duration vs. 4 weeks in children); most common anxiety disorder in children under 12",
      "id": "CPAT-0303"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Body dysmorphic disorder involves preoccupation with perceived flaws not observable to others; repetitive behaviors (mirror checking, reassurance seeking); high suicide risk; CBT with ERP is first-line treatment; cosmetic procedures are generally ineffective",
      "id": "CPAT-0304"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Hoarding disorder is a standalone DSM-5 diagnosis distinct from OCD; hoarding in HD is ego-syntonic (valued) vs. ego-dystonic in OCD; CBT with motivational interviewing is first-line treatment; standard ERP alone has limited efficacy",
      "id": "CPAT-0305"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Trichotillomania: DSM-5 removed the tension/relief criterion; habit reversal training (HRT) is first-line behavioral treatment, not ERP; SSRIs have inconsistent efficacy unlike in OCD",
      "id": "CPAT-0306"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "anxiety-ocd.html",
      "chapter_title": "Anxiety Disorders & OCD",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Excoriation disorder is new to DSM-5 as a formal diagnosis; shares treatment approach with trichotillomania (HRT + CBT); must differentiate from nonsuicidal self-injury, BDD-related picking, and substance-induced picking",
      "id": "CPAT-0307"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "The Callous-Unemotional (CU) Specifier",
      "passage_type": "paragraph",
      "passage": "Unconcerned about performance -- does not show concern about poor performance at school, work, or other activities",
      "id": "CPAT-0308"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "paragraph",
      "passage": "Frequency: Verbal aggression (tantrums, tirades) or physical aggression toward property, animals, or others occurring twice weekly on average for 3 months (need not cause damage), OR three behavioral outbursts involving damage/destruction or physical assault within a 12-month period",
      "id": "CPAT-0309"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "paragraph",
      "passage": "Not better explained by another mental disorder, medical condition, or substance",
      "id": "CPAT-0310"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Genetics: Heritability of antisocial behavior is estimated at 40-60%. CU traits show particularly strong heritability (Viding et al., 2005).",
      "id": "CPAT-0311"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Autonomic underarousal: Low resting heart rate is one of the most replicated biological correlates of antisocial behavior in children (Ortiz & Raine, 2004).",
      "id": "CPAT-0312"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Neurotransmitters: Low serotonin levels associated with impulsive aggression; abnormal dopamine functioning linked to reward sensitivity.",
      "id": "CPAT-0313"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Neuroanatomy: Reduced prefrontal cortex volume and function, reduced amygdala reactivity (particularly in those with CU traits).",
      "id": "CPAT-0314"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Psychological and Social Factors",
      "passage_type": "paragraph",
      "passage": "Patterson's coercion theory (1982): Maladaptive parent-child interaction cycles in which the child learns that escalating aversive behavior is reinforced by parental capitulation, creating a coercive cycle.",
      "id": "CPAT-0315"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Psychological and Social Factors",
      "passage_type": "paragraph",
      "passage": "Social information processing: Dodge and Crick's (1994) model posits that aggressive children show biases in processing social cues, particularly a hostile attribution bias -- the tendency to attribute hostile intent to ambiguous social situations.",
      "id": "CPAT-0316"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Psychological and Social Factors",
      "passage_type": "paragraph",
      "passage": "Attachment: Disorganized attachment in infancy is associated with increased risk for externalizing behavior problems.",
      "id": "CPAT-0317"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Parent-Focused Interventions",
      "passage_type": "paragraph",
      "passage": "Parent Management Training (PMT): Based on Patterson's coercion theory; teaches parents to use positive reinforcement, effective commands, consistent consequences, and to avoid coercive cycles. PMT has the strongest evidence base for ODD and early-onset CD (Kazdin, 2005).",
      "id": "CPAT-0318"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Parent-Focused Interventions",
      "passage_type": "paragraph",
      "passage": "Parent-Child Interaction Therapy (PCIT): For children ages 2-7; uses live coaching (via earpiece) to improve the parent-child relationship and teach effective discipline strategies in real time.",
      "id": "CPAT-0319"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Parent-Focused Interventions",
      "passage_type": "paragraph",
      "passage": "The Incredible Years: Group-based parent training program with additional child and teacher components; reduces conduct problems and increases positive parenting.",
      "id": "CPAT-0320"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Child/Adolescent-Focused Interventions",
      "passage_type": "paragraph",
      "passage": "Problem-Solving Skills Training (PSST): Teaches cognitive problem-solving steps to reduce aggressive responses to social situations; addresses hostile attribution bias.",
      "id": "CPAT-0321"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Child/Adolescent-Focused Interventions",
      "passage_type": "paragraph",
      "passage": "Multisystemic Therapy (MST): Intensive, family- and community-based treatment for serious juvenile offenders; addresses multiple systems (family, peer, school, community); reduces recidivism and out-of-home placements (Henggeler et al., 1998).",
      "id": "CPAT-0322"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "Child/Adolescent-Focused Interventions",
      "passage_type": "paragraph",
      "passage": "Functional Family Therapy (FFT): Addresses family communication patterns and relational dynamics; evidence-based for adolescents with conduct problems.",
      "id": "CPAT-0323"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "ODD requires 4 symptoms for 6 months across three categories: angry/irritable mood, argumentative/defiant behavior, vindictiveness",
      "id": "CPAT-0324"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Conduct disorder requires 3 of 15 criteria in 12 months (at least 1 in past 6 months)",
      "id": "CPAT-0325"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "The \"with limited prosocial emotions\" specifier (CU traits) is new in DSM-5 and associated with proactive aggression, reduced empathy, and lower treatment response",
      "id": "CPAT-0326"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "ASPD requires evidence of CD before age 15 and cannot be diagnosed before age 18",
      "id": "CPAT-0327"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Moffitt's taxonomy: life-course persistent vs. adolescence-limited antisocial behavior",
      "id": "CPAT-0328"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Low resting heart rate is a robust biological correlate of antisocial behavior in youth",
      "id": "CPAT-0329"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Patterson's coercion theory: parent-child coercive cycles maintain oppositional behavior",
      "id": "CPAT-0330"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Dodge's hostile attribution bias: aggressive children attribute hostile intent to ambiguous situations",
      "id": "CPAT-0331"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "conduct-disorders.html",
      "chapter_title": "Disruptive & Conduct Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "IED requires outbursts grossly out of proportion to the provocation and is linked to serotonergic dysfunction",
      "id": "CPAT-0332"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion A: Restriction of energy intake relative to requirements, leading to significantly low body weight in the context of age, sex, developmental trajectory, and physical health",
      "id": "CPAT-0333"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion B: Intense fear of gaining weight or becoming fat, or persistent behavior that interferes with weight gain, even though at a significantly low weight",
      "id": "CPAT-0334"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Criterion C: Disturbance in the way body weight or shape is experienced, undue influence of body weight/shape on self-evaluation, or persistent lack of recognition of the seriousness of the current low body weight",
      "id": "CPAT-0335"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Subtypes",
      "passage_type": "paragraph",
      "passage": "Restricting type: Weight loss achieved primarily through dieting, fasting, and/or excessive exercise. No recurrent binge-eating or purging in the past 3 months.",
      "id": "CPAT-0336"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Subtypes",
      "passage_type": "paragraph",
      "passage": "Binge-eating/purging type: Recurrent episodes of binge eating or purging (self-induced vomiting, misuse of laxatives, diuretics, or enemas) during the past 3 months.",
      "id": "CPAT-0337"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "paragraph",
      "passage": "Recurrent episodes of binge eating (eating a definitively large amount of food in a discrete period with a sense of lack of control)",
      "id": "CPAT-0338"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "paragraph",
      "passage": "Recurrent inappropriate compensatory behaviors to prevent weight gain (purging, fasting, excessive exercise)",
      "id": "CPAT-0339"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "DSM-5 Criteria",
      "passage_type": "paragraph",
      "passage": "Both occur at least once per week for 3 months (reduced from twice per week in DSM-IV)",
      "id": "CPAT-0340"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Pica",
      "passage_type": "paragraph",
      "passage": "The eating behavior is developmentally inappropriate -- mouthing and ingesting nonfood items is not considered abnormal before approximately age 2",
      "id": "CPAT-0341"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Pica",
      "passage_type": "paragraph",
      "passage": "The behavior is not part of a culturally sanctioned or socially normative practice",
      "id": "CPAT-0342"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Pica",
      "passage_type": "paragraph",
      "passage": "If the behavior occurs in the context of another mental disorder (e.g., intellectual disability, autism spectrum disorder), it is sufficiently severe to warrant independent clinical attention",
      "id": "CPAT-0343"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Rumination Disorder",
      "passage_type": "paragraph",
      "passage": "The behavior is not attributable to an associated gastrointestinal or other medical condition (e.g., gastroesophageal reflux, pyloric stenosis)",
      "id": "CPAT-0344"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Rumination Disorder",
      "passage_type": "paragraph",
      "passage": "The behavior does not occur exclusively during the course of anorexia nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake disorder (ARFID)",
      "id": "CPAT-0345"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Rumination Disorder",
      "passage_type": "paragraph",
      "passage": "If occurring in the context of another mental disorder (e.g., intellectual disability), the symptoms are sufficiently severe to warrant independent clinical attention",
      "id": "CPAT-0346"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Genetics: Heritability estimates for AN are approximately 50-80%, among the highest for any psychiatric disorder. BN shows heritability of approximately 55%. Twin studies suggest shared genetic vulnerability across eating disorder diagnoses (Bulik et al., 2006).",
      "id": "CPAT-0347"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Neurotransmitters: Serotonin dysregulation is implicated in both AN and BN. Individuals with BN show reduced serotonergic activity, which may contribute to impulsivity and binge eating. The efficacy of fluoxetine (the only FDA-approved medication for BN) supports serotonergic involvement.",
      "id": "CPAT-0348"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Biological Factors",
      "passage_type": "paragraph",
      "passage": "Neuroendocrine changes: Leptin, ghrelin, and other appetite-regulating hormones are disrupted in eating disorders, though many changes appear to be consequences rather than causes of disordered eating.",
      "id": "CPAT-0349"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Psychological and Sociocultural Factors",
      "passage_type": "paragraph",
      "passage": "Perfectionism and low self-esteem: Perfectionism is a robust risk factor, particularly for AN. The combination of high standards and self-critical evaluation creates vulnerability.",
      "id": "CPAT-0350"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Psychological and Sociocultural Factors",
      "passage_type": "paragraph",
      "passage": "Internalization of the thin ideal: Stice's (2002) dual-pathway model proposes that sociocultural pressure for thinness leads to body dissatisfaction, which promotes both dietary restraint (risk for AN) and negative affect (risk for binge eating).",
      "id": "CPAT-0351"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Psychological and Sociocultural Factors",
      "passage_type": "paragraph",
      "passage": "Cognitive rigidity: Individuals with AN show set-shifting difficulties and weak central coherence (tendency to focus on details rather than global picture), which may be trait markers rather than state-dependent features.",
      "id": "CPAT-0352"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Psychological and Sociocultural Factors",
      "passage_type": "paragraph",
      "passage": "Trauma history: Childhood sexual abuse is a nonspecific risk factor, associated with increased rates of BN and BED in particular.",
      "id": "CPAT-0353"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Narcolepsy",
      "passage_type": "paragraph",
      "passage": "Cataplexy: Brief episodes of sudden bilateral loss of muscle tone triggered by laughter or joking (most specific symptom)",
      "id": "CPAT-0354"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Narcolepsy",
      "passage_type": "paragraph",
      "passage": "Hypocretin (orexin) deficiency: CSF hypocretin-1 levels less than 110 pg/mL (the definitive biomarker)",
      "id": "CPAT-0355"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Narcolepsy",
      "passage_type": "paragraph",
      "passage": "Sleep study findings: REM sleep latency of 15 minutes or less, or MSLT showing mean sleep latency of 8 minutes or less with 2 or more sleep-onset REM periods",
      "id": "CPAT-0356"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Types",
      "passage_type": "paragraph",
      "passage": "Delayed sleep-wake phase type: Habitual sleep-wake timing is delayed, usually by 2+ hours, relative to conventional times. Common in adolescents. The individual cannot fall asleep until very late (e.g., 2-6 AM) and has difficulty waking for school or work.",
      "id": "CPAT-0357"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Types",
      "passage_type": "paragraph",
      "passage": "Advanced sleep-wake phase type: Habitual sleep-wake timing is advanced. More common in older adults. Individuals fall asleep and wake very early (e.g., sleep at 6-8 PM, wake at 2-5 AM).",
      "id": "CPAT-0358"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Types",
      "passage_type": "paragraph",
      "passage": "Shift work type: Insomnia and/or excessive sleepiness due to a work schedule that overlaps the usual sleep period.",
      "id": "CPAT-0359"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Types",
      "passage_type": "paragraph",
      "passage": "Jet lag type: Sleepiness and alertness occurring at inappropriate times relative to local time after travel across time zones.",
      "id": "CPAT-0360"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Types",
      "passage_type": "paragraph",
      "passage": "Non-24-hour sleep-wake type: Pattern of sleep-wake cycles not synchronized to the 24-hour environment. Most common in blind individuals lacking light input to the suprachiasmatic nucleus.",
      "id": "CPAT-0361"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "AN binge-eating/purging type vs. BN: the key distinction is significantly low body weight",
      "id": "CPAT-0362"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "BN frequency threshold: binge/purge at least once per week for 3 months (reduced from twice per week in DSM-IV)",
      "id": "CPAT-0363"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "BED is a new full diagnosis in DSM-5; involves binge eating without compensatory behaviors",
      "id": "CPAT-0364"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "CBT-I is the first-line treatment for insomnia, superior to medication long-term",
      "id": "CPAT-0365"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "REM sleep behavior disorder is a prodromal marker for Parkinson's disease and other synucleinopathies",
      "id": "CPAT-0366"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Pica: eating nonfood substances for 1+ month; not diagnosed before age ~2; associated with ID, ASD, pregnancy, iron deficiency",
      "id": "CPAT-0367"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Rumination disorder: repeated regurgitation for 1+ month; treat with habit reversal and diaphragmatic breathing",
      "id": "CPAT-0368"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "eating-sleep.html",
      "chapter_title": "Eating & Sleep-Wake Disorders",
      "section": "Parasomnias",
      "passage_type": "paragraph",
      "passage": "Parasomnias are abnormal behavioral, experiential, or physiological events occurring during sleep.",
      "id": "CPAT-0369"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Depressed mood most of the day, nearly every day (in children/adolescents, can be irritable mood)",
      "id": "CPAT-0370"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Anhedonia -- markedly diminished interest or pleasure in all or almost all activities",
      "id": "CPAT-0371"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Neurotransmitter Theories",
      "passage_type": "paragraph",
      "passage": "Monoamine hypothesis: Depression results from deficits in serotonin (5-HT), norepinephrine (NE), and/or dopamine (DA). Supported by the mechanism of action of SSRIs, SNRIs, and MAOIs.",
      "id": "CPAT-0372"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Neurotransmitter Theories",
      "passage_type": "paragraph",
      "passage": "HPA axis dysregulation: Chronic stress leads to elevated cortisol via the hypothalamic-pituitary-adrenal axis. Non-suppression on the dexamethasone suppression test is associated with depression, though it lacks diagnostic specificity.",
      "id": "CPAT-0373"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Neurotransmitter Theories",
      "passage_type": "paragraph",
      "passage": "Neuroplasticity model: Reduced brain-derived neurotrophic factor (BDNF) and hippocampal volume reductions are observed in chronic depression (Duman & Monteggia, 2006).",
      "id": "CPAT-0374"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Bipolar I Disorder",
      "passage_type": "paragraph",
      "passage": "Excessive involvement in activities with high potential for painful consequences",
      "id": "CPAT-0375"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Marked affective lability (e.g., mood swings, feeling suddenly sad or tearful, increased sensitivity to rejection)",
      "id": "CPAT-0376"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Physical symptoms such as breast tenderness or swelling, joint or muscle pain, a sensation of bloating, or weight gain",
      "id": "CPAT-0377"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Treatment",
      "passage_type": "paragraph",
      "passage": "SSRIs are the first-line pharmacological treatment for PMDD. Uniquely, SSRIs can be used either continuously (daily throughout the cycle) or only during the luteal phase (the approximately 2 weeks between ovulation and menses onset), with both approaches demonstrating efficacy.",
      "id": "CPAT-0378"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Treatment",
      "passage_type": "paragraph",
      "passage": "Hormonal treatments (oral contraceptives, GnRH agonists) may be used to suppress ovulation and reduce symptom cycling, particularly when SSRIs are insufficient.",
      "id": "CPAT-0379"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Depression",
      "passage_type": "paragraph",
      "passage": "SSRIs (fluoxetine, sertraline, paroxetine, citalopram, escitalopram): First-line treatment; selectively block serotonin reuptake; generally well tolerated with side effects including sexual dysfunction, GI symptoms, and initial anxiety",
      "id": "CPAT-0380"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Depression",
      "passage_type": "paragraph",
      "passage": "SNRIs (venlafaxine, duloxetine, desvenlafaxine): Block both serotonin and norepinephrine reuptake; useful for comorbid pain conditions",
      "id": "CPAT-0381"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Depression",
      "passage_type": "paragraph",
      "passage": "TCAs (amitriptyline, nortriptyline, imipramine): Older antidepressants; effective but more side effects (anticholinergic effects, cardiac conduction delays); lethal in overdose",
      "id": "CPAT-0382"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Depression",
      "passage_type": "paragraph",
      "passage": "MAOIs (phenelzine, tranylcypromine): Require dietary restrictions (tyramine-free diet to avoid hypertensive crisis); generally reserved for treatment-resistant depression or atypical depression",
      "id": "CPAT-0383"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Depression",
      "passage_type": "paragraph",
      "passage": "Atypicals: Bupropion (norepinephrine-dopamine reuptake inhibitor; no sexual side effects; lowers seizure threshold); mirtazapine (increases appetite, causes sedation)",
      "id": "CPAT-0384"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Bipolar Disorder",
      "passage_type": "paragraph",
      "passage": "Lithium: The gold standard mood stabilizer; effective for acute mania and maintenance; requires blood level monitoring (therapeutic range 0.6-1.2 mEq/L); risks include thyroid dysfunction, renal impairment, and teratogenicity (Ebstein's anomaly)",
      "id": "CPAT-0385"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Bipolar Disorder",
      "passage_type": "paragraph",
      "passage": "Anticonvulsants: Valproate (effective for acute mania and mixed states; teratogenic -- neural tube defects); carbamazepine; lamotrigine (particularly effective for bipolar depression prevention)",
      "id": "CPAT-0386"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Pharmacotherapy for Bipolar Disorder",
      "passage_type": "paragraph",
      "passage": "Atypical antipsychotics: Quetiapine, olanzapine, aripiprazole, lurasidone are used for acute mania and/or bipolar depression",
      "id": "CPAT-0387"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Risk Factors",
      "passage_type": "paragraph",
      "passage": "Psychiatric diagnosis -- over 90% of completers had a diagnosable disorder, with depression and substance use being the most common",
      "id": "CPAT-0388"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Risk Factors",
      "passage_type": "paragraph",
      "passage": "Hopelessness -- a stronger predictor of suicidal intent than depression severity (Beck et al., 1985)",
      "id": "CPAT-0389"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Risk Factors",
      "passage_type": "paragraph",
      "passage": "Demographic factors: Males complete suicide at approximately 4 times the rate of females; females attempt suicide approximately 3 times as often as males",
      "id": "CPAT-0390"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Risk Factors",
      "passage_type": "paragraph",
      "passage": "Access to lethal means, family history of suicide, recent losses, social isolation",
      "id": "CPAT-0391"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "MDD requires 5 of 9 symptoms for 2 weeks; must include depressed mood or anhedonia",
      "id": "CPAT-0392"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Bipolar I requires at least one manic episode; depressive episodes are not required",
      "id": "CPAT-0393"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Bipolar II requires at least one hypomanic + one major depressive episode; if mania ever occurs, diagnosis changes to Bipolar I",
      "id": "CPAT-0394"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Atypical depression features: mood reactivity, hypersomnia, leaden paralysis, rejection sensitivity",
      "id": "CPAT-0395"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "PMDD requires 5+ symptoms in the final week before menses; must include at least one core affective symptom",
      "id": "CPAT-0396"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "PMDD requires prospective daily ratings for 2 consecutive cycles for confirmation",
      "id": "CPAT-0397"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "PMDD prevalence: 1.8-5.8% of menstruating women; distinct from PMS by severity and functional impairment",
      "id": "CPAT-0398"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "At least one of the following core affective symptoms must be present:",
      "id": "CPAT-0399"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Plus one or more of the following additional symptoms (to reach a total of at least 5):",
      "id": "CPAT-0400"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "mood-disorders.html",
      "chapter_title": "Bipolar & Depressive Disorders",
      "section": "Suicide Risk Assessment",
      "passage_type": "paragraph",
      "passage": "Suicide is a critical topic for the EPPP. Key risk and protective factors include:",
      "id": "CPAT-0401"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Criteria Changes",
      "passage_type": "paragraph",
      "passage": "Subtypes were relabeled as \"presentations\" to reflect their potential instability over time",
      "id": "CPAT-0402"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Etiology",
      "passage_type": "paragraph",
      "passage": "Genetics: ADHD is highly heritable (approximately 74%). It is polygenic, with dopamine-related genes (DRD4, DAT1) implicated.",
      "id": "CPAT-0403"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Etiology",
      "passage_type": "paragraph",
      "passage": "Neurobiology: Dysregulation of dopamine and norepinephrine in prefrontal-striatal circuits. Structural imaging shows reduced volume in prefrontal cortex, basal ganglia, and cerebellum.",
      "id": "CPAT-0404"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Etiology",
      "passage_type": "paragraph",
      "passage": "Environmental risk factors: Prenatal tobacco and alcohol exposure, low birth weight, prematurity, and lead exposure.",
      "id": "CPAT-0405"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Domain A: Social Communication and Social Interaction (all 3 required)",
      "passage_type": "paragraph",
      "passage": "Deficits in social-emotional reciprocity (e.g., abnormal social approach, failure of back-and-forth conversation, reduced sharing of interests/emotions)",
      "id": "CPAT-0406"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Domain A: Social Communication and Social Interaction (all 3 required)",
      "passage_type": "paragraph",
      "passage": "Deficits in nonverbal communicative behaviors (e.g., poor eye contact, abnormalities in body language, deficits in understanding/use of gestures)",
      "id": "CPAT-0407"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Domain A: Social Communication and Social Interaction (all 3 required)",
      "passage_type": "paragraph",
      "passage": "Deficits in developing, maintaining, and understanding relationships (e.g., difficulty adjusting behavior to social contexts, difficulty sharing imaginative play, absence of interest in peers)",
      "id": "CPAT-0408"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Domain B: Restricted, Repetitive Behaviors (at least 2 of 4 required)",
      "passage_type": "paragraph",
      "passage": "Stereotyped or repetitive motor movements, use of objects, or speech (echolalia, idiosyncratic phrases)",
      "id": "CPAT-0409"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Domain B: Restricted, Repetitive Behaviors (at least 2 of 4 required)",
      "passage_type": "paragraph",
      "passage": "Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment",
      "id": "CPAT-0410"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Methylphenidate (Ritalin, Concerta): Blocks dopamine and norepinephrine reuptake",
      "id": "CPAT-0411"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Amphetamine salts (Adderall, Vyvanse): Block reuptake and increase release of dopamine and norepinephrine",
      "id": "CPAT-0412"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Behavioral and Psychosocial Interventions",
      "passage_type": "paragraph",
      "passage": "Behavioral parent training: Teaching parents contingency management strategies (positive reinforcement, token economies, time-out)",
      "id": "CPAT-0413"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Behavioral and Psychosocial Interventions",
      "passage_type": "paragraph",
      "passage": "Classroom-based behavioral interventions: Daily report cards, token systems, classroom accommodations (preferential seating, breaks, extended time)",
      "id": "CPAT-0414"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Behavioral and Psychosocial Interventions",
      "passage_type": "paragraph",
      "passage": "Organizational skills training: Particularly important for the predominantly inattentive presentation",
      "id": "CPAT-0415"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Behavioral and Psychosocial Interventions",
      "passage_type": "paragraph",
      "passage": "Social skills training: Effectiveness is debated; best when integrated into naturalistic settings",
      "id": "CPAT-0416"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Specifiers",
      "passage_type": "paragraph",
      "passage": "With impairment in reading (encompasses what was formerly called dyslexia): word reading accuracy, reading rate/fluency, reading comprehension",
      "id": "CPAT-0417"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Specifiers",
      "passage_type": "paragraph",
      "passage": "With impairment in written expression (encompasses dysgraphia): spelling accuracy, grammar/punctuation, clarity/organization",
      "id": "CPAT-0418"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "Specifiers",
      "passage_type": "paragraph",
      "passage": "With impairment in mathematics (encompasses dyscalculia): number sense, math facts, calculation, math reasoning",
      "id": "CPAT-0419"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Tic Disorder Hierarchy",
      "passage_type": "paragraph",
      "passage": "Tourette's disorder: Both multiple motor and one or more vocal tics present at some time (not necessarily concurrently). Onset before age 18. Duration more than 1 year. Tics wax and wane.",
      "id": "CPAT-0420"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Tic Disorder Hierarchy",
      "passage_type": "paragraph",
      "passage": "Persistent (chronic) motor or vocal tic disorder: Single or multiple motor OR vocal tics (not both). Onset before 18. Duration more than 1 year.",
      "id": "CPAT-0421"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Tic Disorder Hierarchy",
      "passage_type": "paragraph",
      "passage": "Provisional tic disorder: Single or multiple motor and/or vocal tics. Duration less than 1 year since first onset. Onset before 18.",
      "id": "CPAT-0422"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "ASD consolidated autistic disorder, Asperger's, CDD, and PDD-NOS into one diagnosis",
      "id": "CPAT-0423"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "ASD severity: Level 1 (requiring support), Level 2 (substantial support), Level 3 (very substantial support)",
      "id": "CPAT-0424"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Former Asperger's diagnosis maps to ASD Level 1 without intellectual/language impairment",
      "id": "CPAT-0425"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "SLD is a unified diagnosis with specifiers for reading, written expression, and mathematics",
      "id": "CPAT-0426"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Intellectual disability severity now based on adaptive functioning, not IQ alone",
      "id": "CPAT-0427"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Tourette's requires both motor AND vocal tics for more than 1 year, onset before age 18",
      "id": "CPAT-0428"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "ADHD heritability is approximately 74%; dopamine and norepinephrine are the key neurotransmitters",
      "id": "CPAT-0429"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "neurodevelopmental.html",
      "chapter_title": "Neurodevelopmental Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "ASD requires deficits in both of the following domains:",
      "id": "CPAT-0430"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "General Diagnostic Criteria for Personality Disorders",
      "passage_type": "paragraph",
      "passage": "Affectivity -- range, intensity, lability, and appropriateness of emotional response",
      "id": "CPAT-0431"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Borderline Personality Disorder (BPD)",
      "passage_type": "paragraph",
      "passage": "Pattern of unstable and intense interpersonal relationships (idealization/devaluation, \"splitting\")",
      "id": "CPAT-0432"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Criterion A: Level of Personality Functioning",
      "passage_type": "paragraph",
      "passage": "Identity: Experience of oneself as unique; self-esteem stability; emotional range",
      "id": "CPAT-0433"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Criterion A: Level of Personality Functioning",
      "passage_type": "paragraph",
      "passage": "Self-direction: Pursuit of goals; self-reflective functioning; internal standards",
      "id": "CPAT-0434"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Criterion A: Level of Personality Functioning",
      "passage_type": "paragraph",
      "passage": "Empathy: Comprehension of others' experiences; tolerance of differing perspectives",
      "id": "CPAT-0435"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Prevalence",
      "passage_type": "paragraph",
      "passage": "Cluster A: Approximately 5.7% total (paranoid 2.3-4.4%, schizoid 3.1-4.9%, schizotypal 3.3-3.9%)",
      "id": "CPAT-0436"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Prevalence",
      "passage_type": "paragraph",
      "passage": "Cluster B: Approximately 1.5-6% (antisocial 1-4% with higher rates in males, borderline 1.6-5.9%, histrionic 1.8%, narcissistic 0-6.2%)",
      "id": "CPAT-0437"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Prevalence",
      "passage_type": "paragraph",
      "passage": "Cluster C: Approximately 2.4-6% (avoidant 2.4%, dependent 0.5-0.6%, OCPD 2.1-7.9%)",
      "id": "CPAT-0438"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Cluster A (odd/eccentric): Paranoid, Schizoid, Schizotypal -- genetically linked to schizophrenia",
      "id": "CPAT-0439"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Psychopathy (PCL-R) is narrower than ASPD -- most ASPD do not meet PCL-R psychopathy criteria",
      "id": "CPAT-0440"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "BPD's core features: splitting, abandonment fears, identity disturbance, affective instability",
      "id": "CPAT-0441"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "The AMPD uses Level of Personality Functioning (Criterion A) and pathological traits (Criterion B)",
      "id": "CPAT-0442"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Kohut (empathic mirroring) vs. Kernberg (confrontation of defenses) for narcissistic pathology",
      "id": "CPAT-0443"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Criterion A: Level of Personality Functioning",
      "passage_type": "paragraph",
      "passage": "Assessed using the Level of Personality Functioning Scale (LPFS), which evaluates impairments across four elements:",
      "id": "CPAT-0444"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "personality-disorders.html",
      "chapter_title": "Personality Disorders",
      "section": "Criterion B: Pathological Personality Traits",
      "passage_type": "paragraph",
      "passage": "Organized into five broad trait domains (with 25 trait facets):",
      "id": "CPAT-0445"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Negative Symptoms",
      "passage_type": "paragraph",
      "passage": "Diminished emotional expression (flat/blunted affect): Reductions in facial expression, eye contact, voice intonation, and hand/body movements",
      "id": "CPAT-0446"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Negative Symptoms",
      "passage_type": "paragraph",
      "passage": "Avolition: Decrease in motivated, self-initiated, purposeful activities (sitting for long periods, showing little interest in work or social activities)",
      "id": "CPAT-0447"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Cognitive Symptoms",
      "passage_type": "paragraph",
      "passage": "Executive functioning difficulties (planning, abstract thinking, cognitive flexibility)",
      "id": "CPAT-0448"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "The Dopamine Hypothesis",
      "passage_type": "paragraph",
      "passage": "Original version: Excess dopamine activity causes schizophrenia. Supported by the correlation between antipsychotic efficacy and D2 receptor blockade, and the observation that dopamine agonists (e.g., amphetamines) can induce psychotic symptoms.",
      "id": "CPAT-0449"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "The Dopamine Hypothesis",
      "passage_type": "paragraph",
      "passage": "Revised version (Davis et al., 1991): Mesolimbic dopamine hyperactivity (ventral tegmental area to nucleus accumbens/limbic system) underlies positive symptoms, while mesocortical dopamine hypoactivity (VTA to prefrontal cortex) underlies negative and cognitive symptoms.",
      "id": "CPAT-0450"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Antipsychotic Medications",
      "passage_type": "clinical_note",
      "passage": "Tardive dyskinesia: Involuntary repetitive movements, especially orofacial (onset months to years; may be irreversible)",
      "id": "CPAT-0451"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Antipsychotic Medications",
      "passage_type": "clinical_note",
      "passage": "Neuroleptic malignant syndrome (NMS): Medical emergency with high fever, muscle rigidity, autonomic instability, altered consciousness; treat with dantrolene and bromocriptine",
      "id": "CPAT-0452"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Psychosocial Treatments",
      "passage_type": "paragraph",
      "passage": "Family psychoeducation: Reduces relapse by addressing expressed emotion and improving family coping; one of the most effective psychosocial interventions",
      "id": "CPAT-0453"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Psychosocial Treatments",
      "passage_type": "paragraph",
      "passage": "Social skills training: Structured behavioral approach to improve interpersonal functioning",
      "id": "CPAT-0454"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Psychosocial Treatments",
      "passage_type": "paragraph",
      "passage": "Cognitive remediation therapy: Targets cognitive deficits through structured exercises",
      "id": "CPAT-0455"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Psychosocial Treatments",
      "passage_type": "paragraph",
      "passage": "Assertive community treatment (ACT): Intensive, team-based community support for high-need individuals; reduces hospitalization",
      "id": "CPAT-0456"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Psychosocial Treatments",
      "passage_type": "paragraph",
      "passage": "Supported employment: Individual placement and support (IPS) model has strong evidence",
      "id": "CPAT-0457"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Psychosocial Treatments",
      "passage_type": "paragraph",
      "passage": "CBT for psychosis (CBTp): Helps patients evaluate and reframe delusional beliefs; reduces distress",
      "id": "CPAT-0458"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Phases of Illness",
      "passage_type": "paragraph",
      "passage": "Premorbid phase: Subtle cognitive, motor, and social deficits may be present in childhood",
      "id": "CPAT-0459"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Phases of Illness",
      "passage_type": "paragraph",
      "passage": "Prodromal phase: Gradual decline in functioning; attenuated psychotic symptoms; social withdrawal; typically lasts months to years",
      "id": "CPAT-0460"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Phases of Illness",
      "passage_type": "paragraph",
      "passage": "Active (psychotic) phase: Full diagnostic criteria are met; positive symptoms prominent",
      "id": "CPAT-0461"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Phases of Illness",
      "passage_type": "paragraph",
      "passage": "Residual phase: Active-phase symptoms diminish; negative symptoms and cognitive deficits persist",
      "id": "CPAT-0462"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Schizophrenia requires 2+ Criterion A symptoms for 1 month within 6 months of continuous disturbance",
      "id": "CPAT-0463"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "At least one Criterion A symptom must be delusions, hallucinations, or disorganized speech",
      "id": "CPAT-0464"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Auditory hallucinations are most common in schizophrenia; visual hallucinations suggest medical etiology",
      "id": "CPAT-0465"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Dopamine hypothesis: mesolimbic hyperactivity = positive symptoms; mesocortical hypoactivity = negative/cognitive symptoms",
      "id": "CPAT-0466"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Glutamate (NMDA) hypofunction better explains negative and cognitive symptoms; PCP/ketamine model",
      "id": "CPAT-0467"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "D2 blockade in nigrostriatal pathway = EPS; in tuberoinfundibular pathway = hyperprolactinemia",
      "id": "CPAT-0468"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Better prognosis: late onset, acute onset, female, good premorbid functioning, mood symptoms",
      "id": "CPAT-0469"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "High expressed emotion (criticism, hostility, overinvolvement) predicts higher relapse rates",
      "id": "CPAT-0470"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Cognitive deficits are present before psychosis onset and are poorly treated by antipsychotics",
      "id": "CPAT-0471"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Delusions",
      "passage_type": "paragraph",
      "passage": "Delusions are fixed beliefs that are not amenable to change in light of conflicting evidence. Common types include:",
      "id": "CPAT-0472"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "schizophrenia.html",
      "chapter_title": "Schizophrenia Spectrum",
      "section": "Course and Prognosis",
      "passage_type": "paragraph",
      "passage": "Schizophrenia typically follows a course with distinct phases:",
      "id": "CPAT-0473"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Biopsychosocial Etiology",
      "passage_type": "paragraph",
      "passage": "Biological factors: Vascular disease, diabetes, hormonal imbalances (low testosterone, hyperprolactinemia), neurological conditions, medications (SSRIs are the most common medication-related cause, particularly for delayed orgasm and decreased desire), substance use (alcohol, opioids)",
      "id": "CPAT-0474"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Biopsychosocial Etiology",
      "passage_type": "paragraph",
      "passage": "Psychological factors: Performance anxiety (spectating, as described by Masters & Johnson), relationship distress, depression, anxiety, history of sexual trauma, negative body image, restrictive sexual attitudes",
      "id": "CPAT-0475"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Biopsychosocial Etiology",
      "passage_type": "paragraph",
      "passage": "Sociocultural factors: Cultural and religious prohibitions, inadequate sexual education, gender role expectations",
      "id": "CPAT-0476"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Paraphilic Disorder Treatment",
      "passage_type": "paragraph",
      "passage": "Cognitive-behavioral therapy: Cognitive restructuring of distorted thinking, relapse prevention planning, social skills training",
      "id": "CPAT-0477"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Paraphilic Disorder Treatment",
      "passage_type": "paragraph",
      "passage": "Aversion therapy: Pairing paraphilic stimuli with aversive consequences (covert sensitization uses imagined aversive scenes)",
      "id": "CPAT-0478"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Paraphilic Disorder Treatment",
      "passage_type": "paragraph",
      "passage": "Orgasmic reconditioning: Redirecting arousal patterns toward appropriate stimuli",
      "id": "CPAT-0479"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Paraphilic Disorder Treatment",
      "passage_type": "paragraph",
      "passage": "Pharmacotherapy: Antiandrogens (medroxyprogesterone acetate/Depo-Provera, cyproterone acetate) reduce testosterone and sexual drive; SSRIs may reduce paraphilic urges; GnRH agonists (leuprolide) for severe cases (\"chemical castration\")",
      "id": "CPAT-0480"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Differentiating Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "Medical conditions: Diabetes, cardiovascular disease, neurological conditions (multiple sclerosis, spinal cord injury), endocrine disorders (hypogonadism, thyroid dysfunction), and pelvic conditions must be ruled out",
      "id": "CPAT-0481"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Differentiating Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "Medication effects: SSRIs (most common medication cause), antihypertensives, antipsychotics, anticonvulsants, and opioids can all impair sexual function. SSRI-induced sexual dysfunction affects 30-70% of patients and involves decreased desire, delayed orgasm, and erectile difficulties",
      "id": "CPAT-0482"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Differentiating Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "Substance effects: Alcohol acutely impairs arousal and orgasm; chronic use causes hormonal changes. Opioids significantly reduce testosterone and sexual desire",
      "id": "CPAT-0483"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Differentiating Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "Relationship factors: Partner sexual dysfunction, relationship conflict, and differing desire levels must be assessed. DSM-5 requires that the dysfunction is not better explained by relationship distress or other significant stressors",
      "id": "CPAT-0484"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Differentiating Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "Cultural factors: Cultural expectations about sexual performance, sexual knowledge, and attitudes toward sexual behavior vary widely and must be considered in assessment",
      "id": "CPAT-0485"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Assessment of Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "Clinical interview: Detailed sexual history, pattern of urges/fantasies/behaviors, history of offenses",
      "id": "CPAT-0486"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Assessment of Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "Penile plethysmography (PPG): Measures penile blood flow in response to visual and auditory stimuli; used primarily in forensic assessment of sexual interest patterns (e.g., pedophilic interest). Has reliability and ethical concerns",
      "id": "CPAT-0487"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Assessment of Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "Viewing time measures: Assess attention allocation to sexual stimuli as an indirect measure of sexual interest",
      "id": "CPAT-0488"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Assessment of Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "Actuarial risk assessment tools: Static-99R, STABLE-2007, and ACUTE-2007 assess static and dynamic risk factors for sexual recidivism",
      "id": "CPAT-0489"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Assessment of Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "Psychometric instruments: Multiphasic Sex Inventory, Clarke Sexual History Questionnaire",
      "id": "CPAT-0490"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "DSM-5 combined HSDD and female sexual arousal disorder into Female Sexual Interest/Arousal Disorder",
      "id": "CPAT-0491"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "DSM-5 combined vaginismus and dyspareunia into Genito-Pelvic Pain/Penetration Disorder",
      "id": "CPAT-0492"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Sexual dysfunctions require symptoms for at least 6 months on 75-100% of occasions",
      "id": "CPAT-0493"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Paraphilia (atypical interest) vs. paraphilic disorder (causes distress/impairment or involves nonconsent)",
      "id": "CPAT-0494"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Pedophilic disorder: individual must be at least 16 and at least 5 years older than the child",
      "id": "CPAT-0495"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Gender identity disorder renamed to gender dysphoria to emphasize distress, not identity",
      "id": "CPAT-0496"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Masters & Johnson's sexual response cycle: excitement, plateau, orgasm, resolution",
      "id": "CPAT-0497"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Sensate focus is the key behavioral intervention for sexual dysfunctions (Masters & Johnson)",
      "id": "CPAT-0498"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Gender dysphoria in childhood persists into adulthood in approximately 12-27% of cases",
      "id": "CPAT-0499"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Biopsychosocial Etiology",
      "passage_type": "paragraph",
      "passage": "Sexual dysfunctions arise from the interaction of biological, psychological, and sociocultural factors:",
      "id": "CPAT-0500"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Paraphilic Disorder Treatment",
      "passage_type": "paragraph",
      "passage": "Treatment approaches for paraphilic disorders include:",
      "id": "CPAT-0501"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Differentiating Sexual Dysfunctions",
      "passage_type": "paragraph",
      "passage": "Accurate assessment of sexual dysfunctions requires consideration of several factors:",
      "id": "CPAT-0502"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "sexual-disorders.html",
      "chapter_title": "Sexual Disorders & Gender Dysphoria",
      "section": "Assessment of Paraphilic Disorders",
      "passage_type": "paragraph",
      "passage": "Assessment of paraphilic disorders, particularly in forensic contexts, typically includes:",
      "id": "CPAT-0503"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Risky Use (Criteria 8-9)",
      "passage_type": "paragraph",
      "passage": "Continued use despite knowledge of having a physical or psychological problem caused or exacerbated by the substance",
      "id": "CPAT-0504"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Pharmacological Criteria (Criteria 10-11)",
      "passage_type": "paragraph",
      "passage": "Tolerance: Need for markedly increased amounts to achieve desired effect, or markedly diminished effect with continued use of the same amount",
      "id": "CPAT-0505"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Pharmacological Criteria (Criteria 10-11)",
      "passage_type": "paragraph",
      "passage": "Withdrawal: The characteristic withdrawal syndrome for the substance, or the substance is taken to relieve or avoid withdrawal symptoms",
      "id": "CPAT-0506"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Alcohol-Related Medical Conditions",
      "passage_type": "paragraph",
      "passage": "Wernicke's encephalopathy: Acute condition caused by thiamine (vitamin B1) deficiency. Classic triad: confusion, ataxia, and ophthalmoplegia (eye movement abnormalities). A medical emergency requiring IV thiamine.",
      "id": "CPAT-0507"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Alcohol-Related Medical Conditions",
      "passage_type": "paragraph",
      "passage": "Korsakoff's syndrome: Chronic condition following untreated Wernicke's. Characterized by severe anterograde amnesia (inability to form new memories) and confabulation. Often irreversible.",
      "id": "CPAT-0508"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Alcohol-Related Medical Conditions",
      "passage_type": "paragraph",
      "passage": "Fetal alcohol spectrum disorders: Leading preventable cause of intellectual disability. Features include facial dysmorphology, growth deficiency, and CNS dysfunction.",
      "id": "CPAT-0509"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "The Opioid Overdose Triad",
      "passage_type": "paragraph",
      "passage": "Respiratory depression (slow, shallow, or absent breathing) -- the primary cause of death in opioid overdose",
      "id": "CPAT-0510"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Naloxone (Narcan)",
      "passage_type": "paragraph",
      "passage": "Onset of action within 2-5 minutes when administered intravenously (slightly longer intranasally or intramuscularly)",
      "id": "CPAT-0511"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Naloxone (Narcan)",
      "passage_type": "paragraph",
      "passage": "Duration of action is 30-90 minutes, which is often shorter than the duration of action of the opioid itself -- therefore, repeated doses may be necessary to prevent recurrence of respiratory depression",
      "id": "CPAT-0512"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Naloxone (Narcan)",
      "passage_type": "paragraph",
      "passage": "Administration can precipitate acute opioid withdrawal in dependent individuals, but this is not life-threatening",
      "id": "CPAT-0513"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "Naloxone (Narcan)",
      "passage_type": "paragraph",
      "passage": "Available in intranasal, intramuscular, intravenous, and subcutaneous formulations; widely available without a prescription in many states",
      "id": "CPAT-0514"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "The Mesolimbic Dopamine Pathway",
      "passage_type": "paragraph",
      "passage": "Stimulants (cocaine, amphetamines): Directly increase dopamine by blocking reuptake or increasing release",
      "id": "CPAT-0515"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "The Mesolimbic Dopamine Pathway",
      "passage_type": "paragraph",
      "passage": "Opioids: Disinhibit dopamine neurons by inhibiting GABAergic interneurons in the VTA",
      "id": "CPAT-0516"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "The Mesolimbic Dopamine Pathway",
      "passage_type": "paragraph",
      "passage": "Alcohol: Enhances GABA and inhibits glutamate; also indirectly increases dopamine release",
      "id": "CPAT-0517"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Needs to gamble with increasing amounts of money to achieve the desired excitement (tolerance)",
      "id": "CPAT-0518"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Is restless or irritable when attempting to cut down or stop gambling (withdrawal)",
      "id": "CPAT-0519"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Has made repeated unsuccessful efforts to control, cut back, or stop gambling (loss of control)",
      "id": "CPAT-0520"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Is often preoccupied with gambling (e.g., reliving past gambling experiences, planning the next venture, thinking of ways to obtain money)",
      "id": "CPAT-0521"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Often gambles when feeling distressed (e.g., helpless, guilty, anxious, depressed)",
      "id": "CPAT-0522"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "After losing money gambling, often returns another day to get even (\"chasing\" losses)",
      "id": "CPAT-0523"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Has jeopardized or lost a significant relationship, job, or educational/career opportunity because of gambling",
      "id": "CPAT-0524"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "DSM-5 Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Relies on others to provide money to relieve desperate financial situations caused by gambling",
      "id": "CPAT-0525"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "DSM-5 eliminated the abuse/dependence distinction; single SUD diagnosis with mild/moderate/severe specifiers",
      "id": "CPAT-0526"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "SUD requires 2 of 11 criteria in 12 months; craving is new; legal problems removed",
      "id": "CPAT-0527"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Wernicke's encephalopathy = thiamine deficiency (confusion, ataxia, ophthalmoplegia); Korsakoff's = anterograde amnesia + confabulation",
      "id": "CPAT-0528"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Opioid treatments: methadone (full agonist), buprenorphine (partial agonist), naltrexone (antagonist)",
      "id": "CPAT-0529"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Stages of Change: precontemplation, contemplation, preparation, action, maintenance",
      "id": "CPAT-0530"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Motivational interviewing is non-confrontational, uses OARS technique, aligned with stages of change",
      "id": "CPAT-0531"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Opioid overdose triad: respiratory depression + miosis (pinpoint pupils) + decreased consciousness",
      "id": "CPAT-0532"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Naloxone (Narcan): opioid antagonist; onset 2-5 minutes IV; may need repeated doses; Good Samaritan laws protect bystanders",
      "id": "CPAT-0533"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Gambling disorder: first non-substance behavioral addiction in DSM-5; 4+ of 9 criteria in 12 months",
      "id": "CPAT-0534"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Gambling disorder criteria parallel SUD (tolerance, withdrawal, loss of control); neurobiology involves dopamine reward system; prevalence 0.4-1% adults",
      "id": "CPAT-0535"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "substance-disorders.html",
      "chapter_title": "Substance Use Disorders",
      "section": "The Opioid Overdose Triad",
      "passage_type": "paragraph",
      "passage": "The classic presentation of opioid overdose involves a characteristic triad of three signs:",
      "id": "CPAT-0536"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Criterion A: Exposure to Traumatic Event",
      "passage_type": "paragraph",
      "passage": "Learning that the event occurred to a close family member or friend (must be violent or accidental for death)",
      "id": "CPAT-0537"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Criterion A: Exposure to Traumatic Event",
      "passage_type": "paragraph",
      "passage": "Experiencing repeated or extreme exposure to aversive details of traumatic events (e.g., first responders; does not include exposure through media unless work-related)",
      "id": "CPAT-0538"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Cluster B: Intrusion Symptoms (1 or more)",
      "passage_type": "paragraph",
      "passage": "Dissociative reactions (flashbacks) where the individual feels or acts as if the event is recurring",
      "id": "CPAT-0539"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Cluster C: Avoidance (1 or more)",
      "passage_type": "paragraph",
      "passage": "Avoidance of or efforts to avoid external reminders (people, places, activities, situations)",
      "id": "CPAT-0540"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Cluster D: Negative Alterations in Cognitions and Mood (2 or more)",
      "passage_type": "paragraph",
      "passage": "Persistent distorted cognitions about the cause or consequences of the event (self-blame)",
      "id": "CPAT-0541"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "DSM-5-TR Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Preoccupation with thoughts or memories of the deceased (in children/adolescents, preoccupation may focus on the circumstances of the death)",
      "id": "CPAT-0542"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "DSM-5-TR Diagnostic Criteria",
      "passage_type": "paragraph",
      "passage": "Difficulty reintegrating into one's relationships and activities after the death",
      "id": "CPAT-0543"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Dissociative Identity Disorder (DID)",
      "passage_type": "paragraph",
      "passage": "Recurrent gaps in recall of everyday events, important personal information, and/or traumatic events (beyond ordinary forgetting)",
      "id": "CPAT-0544"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "First-Line Psychotherapies",
      "passage_type": "paragraph",
      "passage": "Prolonged Exposure (PE): Developed by Foa et al., involves repeated, systematic exposure to trauma-related memories (imaginal exposure) and avoided situations (in vivo exposure). Based on emotional processing theory -- the idea that fear memories must be activated and modified with corrective information. PE has the largest evidence base for PTSD treatment.",
      "id": "CPAT-0545"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "First-Line Psychotherapies",
      "passage_type": "paragraph",
      "passage": "Cognitive Processing Therapy (CPT): Developed by Resick et al., focuses on identifying and challenging maladaptive beliefs (\"stuck points\") about the trauma, oneself, and the world. Involves written trauma accounts and cognitive restructuring worksheets.",
      "id": "CPAT-0546"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "First-Line Psychotherapies",
      "passage_type": "paragraph",
      "passage": "EMDR (Eye Movement Desensitization and Reprocessing): Developed by Shapiro, involves processing traumatic memories while simultaneously engaging in bilateral stimulation (typically lateral eye movements). Effective but the mechanism of action remains debated -- the specific role of eye movements is controversial, and some argue the exposure component drives efficacy.",
      "id": "CPAT-0547"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "SSRIs (sertraline and paroxetine are FDA-approved for PTSD) are the first-line pharmacological treatment",
      "id": "CPAT-0548"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Pharmacotherapy",
      "passage_type": "paragraph",
      "passage": "Benzodiazepines are NOT recommended for PTSD -- they can interfere with fear extinction learning and may worsen outcomes",
      "id": "CPAT-0549"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "PTSD is no longer an anxiety disorder in DSM-5; it is in Trauma- and Stressor-Related Disorders",
      "id": "CPAT-0550"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "PTSD now has 4 symptom clusters (intrusion, avoidance, negative cognitions/mood, arousal/reactivity)",
      "id": "CPAT-0551"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Adjustment disorder: within 3 months of stressor, resolves within 6 months of stressor termination",
      "id": "CPAT-0552"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "DID debate: posttraumatic model (childhood trauma) vs. sociocognitive model (iatrogenic/cultural)",
      "id": "CPAT-0553"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Somatic symptom disorder: DSM-5 focuses on disproportionate response to symptoms, not whether they are medically explained",
      "id": "CPAT-0554"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Factitious disorder = motivation to assume sick role; malingering = external incentives",
      "id": "CPAT-0555"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "La belle indifference is not a reliable diagnostic indicator for conversion disorder",
      "id": "CPAT-0556"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Prolonged Grief Disorder (DSM-5-TR): death at least 12 months ago (adults) or 6 months (children); yearning/preoccupation + 3 of 8 symptoms",
      "id": "CPAT-0557"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "PGD prevalence: approximately 10% of bereaved individuals; normal grief decreases over time, PGD does not",
      "id": "CPAT-0558"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "EPPP Focus Points",
      "passage_type": "clinical_note",
      "passage": "Complicated Grief Treatment (CGT) by Shear combines elements of IPT and exposure therapy",
      "id": "CPAT-0559"
    },
    {
      "domain_code": "CPAT",
      "domain_name": "Clinical Psychopathology (DSM-5)",
      "chapter_file": "trauma-dissociative.html",
      "chapter_title": "Trauma & Dissociative Disorders",
      "section": "Criterion A: Exposure to Traumatic Event",
      "passage_type": "paragraph",
      "passage": "Exposure to actual or threatened death, serious injury, or sexual violence through one or more of:",
      "id": "CPAT-0560"
    }
  ]
}